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Abstract 
CHRISTOPHER ROBERT NOËL: The FhaB Prodomain of Bordetella Affects the 
Biogenesis of Filamentous Hemaggluttinin, Influencing Bordetella Virulence 
(Under the direction of Peggy Ann Cotter, Ph.D.) 
 
Two-partner secretion (TPS) systems use β-barrel proteins of the Omp85-
TpsB superfamily to transport large exoproteins across the outer membranes of 
Gram-negative bacteria. The Bordetella FHA/FhaC proteins are prototypical of TPS 
systems in which the exoprotein contains a large C-terminal prodomain that is 
removed during translocation. Although it is known that the FhaB prodomain is 
required for FHA function in vivo, its role in FHA maturation has remained 
mysterious. We show here that the FhaB prodomain is required for the 
extracellularly located mature C-terminal domain (MCD) of FHA to achieve its proper 
conformation. We show that the C-terminus of the prodomain is retained 
intracellularly and that sequences within the N-terminus of the prodomain are 
required for this intracellular localization. We also identify the MCD and prodomain 
N-terminus (PNT) as determinants of mature FHA release efficiency. Finally, we 
characterize subdomains at the C-terminus of the prodomain and their effects on 
FHA biogenesis and Bordetella virulence. Our data support a model in which the 
intracellularly located prodomain affects the final conformation of the extracellularly 
located MCD. 
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Chapter I – Introduction 
 
Type 5 Secretion Systems of Gram-negative bacteria 
 
Protein secretion – the trafficking of protein from the cytoplasm of the cell to 
the cell surface – is ubiquitous to all forms of life (Yen et al., 2002; Henderson et al., 
2004; Albers et al., 2006; Scott and Barnett, 2006; Braakman and Bulleid, 2011). 
Gram-negative bacteria have evolved numerous methods to secrete polypeptides. 
One of these methods, the Type 5 Secretion System (T5SS), is used to secrete 
particularly large proteins. The Type 5 secreted exoproteins, many of which are 
virulence factors, can function as adhesins, cytolysins, proteases, or contact-
dependent inhibitors of growth (Cotter et al., 1998; Aoki et al., 2005; Hertle, 2005; St 
Geme and Yeo, 2009). The T5SS also stands out for its mechanistic simplicity, 
seemingly requiring only a small set of proteins (two to three) for secretion 
(Henderson et al., 2004; Jacob-Dubuisson et al., 2004; Leo et al., 2012). Based on 
specific features of the various secretion systems encompassed, T5SS can be 
divided into different families of secretion pathways that likely employ conserved 
mechanics to secrete protein. These families consist of classical autotransporters, 
trimeric autotransporters, intimins/invasins, and two-partner secretion (Figure 1). 
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Figure 1 
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The T5SS consists of four families
A. Classical autotransporters (ATs). ATs use a C-terminal transporter domain (purple) 
and a central autochaperone (orange) to secrete an N-terminal passenger domain 
(blue).
B. Trimeric autotransporters (TATs). TATs use a homo-trimeric transporter domain 
(purple) to secrete three passenger domains (shades of blue) to the extracellular 
space, where they homo-trimerize.
C. Intimins/Invasins. Proteins of this family use an N-terminal transporter domain 
(purple) and a central autochaperone (orange) to secrete a C-terminal passenger 
domain (blue).
D. Two-partner secretion (TPS). TPS systems use a TpsB transporter protein 
(purple) to secrete a TpsA protein (blue). Topology varies within TPS and, therefore, 
is not labeled in the secreted form.
	   3	  
N-terminal extensions of signal peptides in T5SS 
 
A unique characteristic of some T5SS proteins is the presence of N-terminal 
extensions on their signal peptides (Lambert-Buisine et al., 1998; Sijbrandi et al., 
2003; Chevalier et al., 2004; Szabady et al., 2005; Desvaux et al., 2007; Hiss and 
Schneider, 2009). Although N-terminal extensions are broadly represented across a 
variety of T5SS proteins, the function of these extensions remains unknown. Sijbrani 
et al. reported that an autotransporter containing an N-terminal extension is targeted 
to the general secretory system (Sec) in a co-translational, signal recognition 
particle-dependent manner, but they did not demonstrate that the N-terminal 
extension specifically plays any role in this targeting (Sijbrandi et al., 2003). 
Conversely, work by Chevalier et al. and Desvaux et al. suggests that the N-terminal 
extension directs post-translational, SecAB-dependent targeting to the SecYEG 
complex (Chevalier et al., 2004; Desvaux et al., 2007). Their separate works also 
indicate that the N-terminal extension delays translocation across the inner 
membrane by Sec. Szabady et al. showed that N-terminal extensions may act in cis 
post-translocationally to affect the folding of the polypeptides to which they are 
attached (Szabady et al., 2005). To summarize, N-terminal extensions do not appear 
to direct co- versus post-translational secretion, but may rather be involved in 
regulating the rate and dynamics of secretion. This hypothesis of secretion 
regulation is particularly attractive as the theme of secretion regulation is a common 
one throughout this dissertation. 
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Classical Autotransporters 
 
Classical autotransporters (ATs) are translated as a single polypeptide. They 
have an N-terminal signal peptide that, in some proteins, contains an N-terminal 
extension (Sijbrandi et al., 2003; Szabady et al., 2005; Desvaux et al., 2007; Hiss 
and Schneider, 2009). C-terminal to the signal peptide is the AT passenger domain, 
which ultimately adopts a β-helical fold and bears the functional domain of the AT 
(Emsley et al., 1996; Dautin and Bernstein, 2007; Khan et al., 2011; van Ulsen, 
2011; Leyton et al., 2012). The C-terminus of the AT folds into an integral outer 
membrane β-barrel that is used to translocate the passenger domain into the 
extracellular space. An autochaperone domain and α-helical linker connect the 
passenger domain to the β-barrel domain and have been implicated in nucleating β-
helical folding of the passenger domain in the extracellular space (Oliver et al., 2003; 
Jacob-Dubuisson et al., 2004; Ieva et al., 2008; Peterson et al., 2010; Leyton et al., 
2012). An attractive hypothesis is that as the C-terminal β-helical portion of the 
passenger domain folds, it serves as a Brownian ratchet that drives secretion of N-
terminal sequences of the passenger domain.  
 
One of the outstanding challenges of AT research is to fully understand the 
mechanics of passenger domain secretion. Two models exist to explain how the 
passenger domain transits from the periplasm to the extracellular space. One states 
that the passenger domain transits as a hairpin through the pore of the β-barrel 
domain, with translocation proceeding in a C- to N-terminal manner (Junker et al., 
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2006; Dautin and Bernstein, 2007; Leyton et al., 2012). Kinetic studies indicate that 
the C-terminal portion of the passenger domain reaches the extracellular space first 
and provides the energetics of extracellular folding of the upstream passenger 
domain (Junker et al., 2009; Renn et al., 2012).  
 
A second model of AT secretion states that AT proteins are not truly self-
sufficient for extracellular localization, but rather that they require the assistance of 
the Bam complex to translocate the passenger domain across the outer membrane. 
According to this model, the passenger domain does not transit through the β-barrel 
domain pore, but associates with the Bam complex in the outer membrane (Skillman 
et al., 2005; Dautin and Bernstein, 2007; Ieva and Bernstein, 2009; Leyton et al., 
2012). This model postulates that upon association with the Bam complex, the Bam 
complex ‘flips’ a partially folded passenger domain across the outer membrane, 
where it subsequently folds into a β-helix. Indeed, the E. coli AT has been shown to 
complex with BamA of the Bam complex (Ieva and Bernstein, 2009).  
 
These two models are not mutually exclusive, though. It is feasible that ATs 
are translocated to the extracellular space (either through the β-domain pore or the 
Bam complex) in a C- to N-terminal vectorial manner that is dependent on the 
activity of the Bam complex – a model that has recently gained traction (Peterson et 
al., 2010). Once AT passenger domains are surface exposed they perform a variety 
of functions, serving in adhesion, proteolysis, motility, enterotoxicity, immune 
evasion, or lipolysis (Henderson et al., 2004; Klemm et al., 2006). 
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Trimeric Autotransporters 
 
Trimeric autotransporters (TATs), so named due to their homo-trimerization in 
the outer membrane, are another family of T5SS. TATs begin with an N-terminal 
signal peptide that sometimes contains an N-terminal extension (Leo et al., 2012), 
which is followed by the passenger domain. As in classical ATs, the passenger 
domain contains the functional and structural portion of the TAT (Cotter et al., 2005; 
Łyskowski et al., 2011; Leo et al., 2012). Unlike classical ATs, however, the 
passenger domain of an individual TAT polypeptide contains only one-third of the 
fully functional passenger domain and the passenger domains of three polypeptides 
co-localize as a homo-trimer at the cell surface, assembling into a coiled coil to 
establish an elongated shaft with an N-terminal functional domain (Łyskowski et al., 
2011; Leo et al., 2012). The C-terminal domain of TAT polypeptides is the β-barrel – 
specifically one third of the final barrel. Like the passenger domain, the individual 
TAT proteins’ β-barrel domains trimerize to assembly a complete integral outer 
membrane β-barrel (Cotter et al., 2005; Leo et al., 2012). It is via this homo-trimeric 
β-barrel that the three passenger domains are thought to reach the cell surface, 
although it is not known whether they translocate across the outer membrane 
concurrently or individually. As with classical ATs, there is evidence that the Bam 
complex is involved in TAT passenger domain secretion (Lehr et al., 2010). Once 
folded on the cell surface, all TATs that have been studied so far appear to function 
as adhesins (Cotter et al., 2005; Łyskowski et al., 2011). 
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Intimins and Invasins 
 
A third class of T5SS is intimins/invasins. Intimin is used by enterpathogenic 
E. coli and enterohemorrhagic E. coli to bind a translocated intimin receptor (Tir) that 
is delivered to host cells by the bacterial Type 3 Secretion System (Nougayrède et 
al., 2003; Niemann et al., 2004; Leo et al., 2012). Invasin is used by Y. 
pseduotuberculosis and Y. enterocolitica to bind integrins of host cells (Isberg and 
Barnes, 2001; Niemann et al., 2004; Leo et al., 2012). Consistent with classical ATs, 
secretion of intimins/invasins has been demonstrated to require periplasmic 
chaperones and the Bam complex (Bodelón et al., 2009). The standout feature of 
these proteins is their domain organization. While classical and trimeric ATs have N-
terminal passenger domains and a C-terminal β-barrel domain, intimins/invasins 
have an N-terminal β-barrel domain and a C-terminal passenger domain. This 
results in a C-terminus that is distal from the cell surface (Leong et al., 1990; 
Batchelor et al., 2000), having likely crossed the outer membrane through the β-
barrel domain as a hairpin that folds in an N- to C-terminal order (Adams et al., 
2005; Tsai et al., 2010). Furthermore, intimins/invasins are distinct from ATs in that 
their extracellular shaft is composed of a series of immunoglobulin-like domains, 
rather than a β-helix (Hamburger et al., 1999; Kelly et al., 1999; Niemann et al., 
2004). Proteins of the intimin/invasin family of T5SS are commonly thought to be 
adhesins – understandable since their namesake proteins function in adherence. 
BipA of Bordetella, however, also belongs to the intimin/invasin family, but does not 
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appear to function in adherence in vitro or persistence in vivo (Stockbauer et al., 
2001), suggesting that intimin/invasin-like proteins may have additional functions. 
 
Overview of Two-Partner Secretion 
 
In the case of the Two-Partner Secretion (TPS) pathway, two proteins are 
involved in surface localization, generically referred to as TpsA and TpsB proteins 
(Jacob-Dubuisson et al., 2004; Newman and Stathopoulos, 2004; Mazar and Cotter, 
2007). TpsA proteins most closely parallel the passenger domains of ATs. They 
have an N-terminal signal peptide that may or may not include an N-terminal 
extension (Chevalier et al., 2004). C-terminal to the signal peptide is the “Two-
Partner Secretion domain” (TPS domain), a hallmark feature of TpsA proteins that is 
involved in translocation of the TpsA protein across the outer membrane (Jacob-
Dubuisson et al., 2004). Beyond the TPS domain, TpsA polypeptide content varies, 
however structure prediction programs suggest a great deal of β-helical structure 
(Makhov et al., 1994; Kajava et al., 2001; Clantin et al., 2004). The second protein 
involved in TPS, the TpsB protein, is an integral outer membrane β-barrel 
transporter, reminiscent of the C-terminal β-domain of ATs (Jacob-Dubuisson et al., 
2004; Mazar and Cotter, 2007). The TpsB protein is required to translocate the TpsA 
protein across the outer membrane. Once it emerges into the extracellular space, 
the TPS domain of the TpsA protein begins to fold into a β-helix (Clantin et al., 2004; 
Jacob-Dubuisson et al., 2004), and in doing so is thought to nucleate further β-
helical folding of downstream TpsA polypeptide as translocation proceeds. Upon 
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secretion, TpsA proteins can serve as adhesins, cytolysins, regulators of host 
response, or contact-dependent growth inhibitors (St Geme et al., 1993; Cotter et al., 
1998; Aoki et al., 2005; Hertle, 2005; Henderson et al., 2012). 
 
TpsB proteins 
 
The TPS pathways employ an integral outer membrane protein to secrete 
cognate TpsA proteins. The translocator proteins, generically referred to as TpsB 
proteins, belong to the Omp85 superfamily (Genevrois et al., 2003; Voulhoux et al., 
2003; Gentle et al., 2004; Voulhoux and Tommassen, 2004; Gentle et al., 2005; 
Werner and Misra, 2005). Present in mitochondria, chloroplasts and Gram-negative 
bacteria, Omp85-like proteins are the most widely distributed class of outer 
membrane proteins across nature (Yen et al., 2002). Proteins belonging to the 
Omp85 superfamily can have between one to five N-terminal polypeptide transport 
associated (POTRA) domains. These domains typically consist of a conserved 
βααββ secondary structure arranged into a globular conformation, despite limited 
conservation of amino acids sequences, even amongst POTRA domains within the 
same protein (Sanchez-Pulido et al., 2003; Clantin et al., 2007; Kim et al., 2007).  
 
TpsB proteins contain an N-terminal signal peptide, which is followed by two 
POTRA domains. POTRA domains of TpsB proteins are periplasmic and are 
required for translocation of TpsA proteins across the outer membrane (Delattre et 
al., 2011). The current model postulates that they serve as the first point of contact 
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between TpsA and TpsB proteins and initiate secretion of the TpsA protein (Hodak 
et al., 2006; Mazar and Cotter, 2007; Delattre et al., 2011). Following the POTRA 
domains is the ~300 aa β-barrel domain (Surana et al., 2006; Clantin et al., 2007; 
Méli et al., 2009). Topological studies of a handful of β-barrel domains suggest that 
TpsB proteins vary widely in their structure (Könninger et al., 1999; Guedin et al., 
2000; Surana et al., 2006). The crystal structure of FhaC, a TpsB protein, from B. 
pertussis has been solved (Clantin et al., 2007) and potentially reveals a great deal 
about TpsB proteins as a whole. The FhaC β-barrel consists of 16 anti-parallel β-
strands with both the N- and C- termini facing into the periplasm (Figure 2). The β-
strands are connected by a series of short periplasmic turns and longer extracellular 
loops. Loop 6 (L6) occupies the FhaC pore in the crystal structure with the tip of the 
loop reaching the periplasm. The tip of the loop contains a VRGY motif that is 
conserved throughout the Omp85 superfamily (Gentle et al., 2005; Moslavac et al., 
2005; Clantin et al., 2007; Delattre et al., 2010). Studies of B. pertussis FhaC in E. 
coli indicate that this motif is required for secretion of a polypeptide corresponding to 
the N-terminal 80 kDa of FhaB (named FHA44) at a step of the secretion 
subsequent to interaction between the TPS domain and POTRA domain (Delattre et 
al., 2010). FhaC additionally contains an α-helix (H1) N-terminal to the POTRA 
domains that occupies the FhaC pore alongside L6 (Clantin et al., 2007). The 
function of H1 is unknown, however its removal from FhaC does not affect secretion 
of FHA44 by FhaC (Guedin et al., 2000; Méli et al., 2006). This α-helix is predicted to 
occur in some additional, but not all, TpsB proteins (Méli et al., 2009). 
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Figure 2 
Structure of FhaC
At the top is a side view of the ribbon strucute of FhaC. Helix 1 (magenta) is shown 
occupying the FhaC pore. POTRA domains (blue) face into the Bordetella periplasm.  
The FhaC β-barrel (green) is integrated into the Bordetella outer membrane. Loop 6 
of FhaC (orange) co-occupies the FhaC pore. At the bottom is an overhead view of 
the ribbon structure of FhaC, included to better show helix 1 and loop 6 occupying 
the FhaC pore. Images generated in PyMOL.
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Phylogentic categorization of TPS systems into subfamilies 
 
Exoproteins and transporters belonging to the TPS family can be categorized 
into subfamilies based on multiple criteria. One method of categorization is 
phylogenetic analysis of the TPS domains of TpsA proteins. As previously 
mentioned, the TPS domain is a hallmark of the TPS system, necessary for 
secretion of TpsA proteins across the outer membrane. A summarized phylogenetic 
tree was generated by using ClustalW (Figure 3). ClustalW alignment of previously 
characterized TpsA proteins and analysis of their phylogenetic tree reveals that 
these proteins arrange into four subfamilies best represented by FhaB, HMW1A, 
ShlA and CdiA (Jacob-Dubuisson et al., 2001; Clantin et al., 2004; Choi et al., 2007; 
Mazar and Cotter, 2007). While the FhaB, ShlA and CdiA subfamilies show high 
similarity across their TPS domains, the HMW1A subfamily differs across most of 
the domain. The non-HMW1A TPS domains contain less conserved (LC) and 
conserved (C) subdomains, with subdomains arranged LC1, C1, LC2, and C2 
(Clantin et al., 2004). It is thought that the LC subdomains confer TpsA/TpsB 
specificity while the C subdomains are necessary for secretion mechanics 
regardless of TPS subfamily (Hodak et al., 2006). The C1 subdomain stands out 
because it contains two motifs – NPNL and NPNGI – that are required for TpsA 
secretion in most TPS subfamilies (Schönherr et al., 1993; Jacob-Dubuisson et al., 
1997; Brillard et al., 2002; Ward et al., 2003; Choi et al., 2007). While the HMW1A 
TPS domain also contains – and requires – an NPNGI motif (St Geme and Grass, 
1998), it and members of the HMW1A subfamily lack the NPNL motif. Rather, a  
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Figure 3 
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downstream NTNG motif may contribute to the ability of the TPS domain to mediate 
HMW1A secretion (Grass and St Geme, 2000). LspA1 and LspA2 categorize with 
the HMW1A subfamily based on their TPS domain, though LspB does not 
phylogenetically categorize with HMW1B (described below). 
 
The basis for TpsA/TpsB specificity likely has as much to do with sequences 
in TpsB proteins’ POTRA domains as it does with sequences in TpsA proteins’ TPS 
domains. Indeed, ClustalW analyses of full-length TpsB proteins (Figure 4A) and just 
their POTRA domains (Figure 4B) reveal that these proteins categorize similarly to 
the TPS domains of their respective TpsA proteins (Jacob-Dubuisson et al., 2004; 
Choi et al., 2007; Jacob-Dubuisson et al., 2009). This phylogenetic correlation 
between TPS domains and POTRA domains strongly suggests that TpsA/TpsB 
interactions are specific within a subfamily, if not strictly to the cognate protein. As 
previously mentioned, phylogenetic characterization of LspB is inconsistent with the 
characterization of LspA1 and LspA2, making it difficult to assign LspAB to a TPS 
subfamily. Experimental evidence corroborates the idea of TpsA/TpsB specificity. It 
has previously been reported that TpsA/TpsB specificity is fairly strict. When 
expressed in E. coli, HpmB of P. mirabilis is incompatible with secretion of FHA44 
(Jacob-Dubuisson et al., 1997). Likewise, FhaC is incompatible with secretion of full-
length HpmA, but ShlB of S. marcescens is capable of secreting HpmA. Though 
FhaC is not able to secrete cytolysins of the ShlA subfamily, it is able to secrete both 
FhaB and FhaS (FhaS will be explained in greater detail on page 40) of Bordetella 
(Julio and Cotter, 2005). LspB of H. ducreyi is similarly able to secrete both LspA1   
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Figure 4
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Figure 4 
 
TpsB proteins can be phylogenetically categorized into subfamilies based on their 
complete peptide and POTRA domain sequences 
 
A. ClustalW analysis of the full sequence of characterized TpsB proteins yields a 
phylogenetic tree that categorizes TpsB proteins into subfamilies. The best-studied 
representatives of these subfamilies are FhaC, HMW1B, CdiB, and ShlB. LspB and 
does not strongly categorize with any subfamily and may represent a fifth subfamily. 
B. ClustalW analysis of the POTRA domains of the proteins examined in Figure 4A 
yields a phylogenetic tree that categorizes TpsB proteins into subfamilies similarly to 
Figure 4A. 
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and LspA2, two TpsA proteins of H. ducreyi that share 86% identity (Ward et al., 
1998; 2004). In the case of nontypeable H. influenzae, two TpsB proteins – HMW1B 
and HMW2B – are functionally interchangeable for the secretion of HMW1A and 
HMW2A when expressed in E. coli (St Geme and Grass, 1998).  
 
Functional categorization of TPS system subfamilies 
 
TPS systems can also be categorized based on functional properties of 
prototypical members of each subfamily (Table 1), providing a basis for functional 
predictions of uncharacterized TpsA proteins based on their subfamily 
categorization. FhaB is an adherence factor and has been shown to be immuno-
suppressive (Urisu et al., 1986; Locht et al., 1993; Cotter et al., 1998; McGuirk and 
Mills, 2000; Julio et al., 2009; Henderson et al., 2012). HMW1A, although belonging 
to a different subfamily, is also involved in adhesion (St Geme et al., 1993; St Geme, 
1994). Members of the CdiA subfamily, best characterized in Burkholderia spp., D. 
dadantii, and a specific strain of E. coli, are involved in contact-dependent growth 
inhibition (Aoki et al., 2005; 2010; Anderson et al., 2012). Members of the ShlA 
subfamily are cytolysins (Poole et al., 1988; Hertle et al., 1999).  
 
Topological categorization of TPS system subfamilies 
 
TPS may be further categorized by extracellular topology. FHA (the mature 
form of FhaB) has its N-terminus associated with the Bordetella outer membrane 
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(Mazar and Cotter, 2007). The C-terminus of the protein is distal from the cell 
surface, likely enabling the adhesive C-terminus to reach out from the bacteria (Julio 
et al., 2009). Although also an adhesin, HMW1A can be distinguished from FHA by 
an opposite orientation, with its C-terminus associated with the H. influenzae outer 
membrane and the N-terminus sticking out (Grass and St Geme, 2000; Dawid et al., 
2001; Buscher et al., 2006). Less is known about CdiA and ShlA subfamily 
topologies. Both are speculated to have C-termini that face out, based on their C-
terminal functional domains (Hertle, 2005; Aoki et al., 2010; Hayes et al., 2010).  
 
Categorization of TPS system subfamilies based on presence of pro-regions 
 
Finally, TPS can be classified based on the presence of pro-regions. FhaB 
has an ~1200 aa “prodomain” at its C-terminus (Delisse-Gathoye et al., 1990; Mazar 
and Cotter, 2006).  The FhaB prodomain has previously been reported to be 
required for FHA-dependent adherence of Bordetella to mammalian cells in vitro and 
tracheal colonization in vivo (Mazar and Cotter, 2006). In HMW1A, an ~370 aa N-
terminal “pro-piece” that contains the TPS domain is cleaved during the secretion 
process (Grass and St Geme, 2000; Yeo et al., 2007). The HMW1A pro-piece 
contains the TPS domain, but additional functions are unknown. Proteins belonging 
to the CdiA and ShlA subfamilies do not appear to have pro-regions. 
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Table 1 - Categorization of TpsA proteins by function, topology and pro-region 
TPS Subfamily Function Topology Pro-Region 
FhaB Adhesion/Immunomodulation C-terminus Out C-terminal 
HMW1A Adhesion N-terminus Out N-terminal 
CdiA Contact-Dependent Growth 
Inhibition 
C-terminus Out None 
ShlA Cytolysin C-terminus Out None 
 
Bordetella bronchiseptica FHA biogenesis 
 
The fhaB open reading frame is 11,130 bp in B. bronchiseptica, our model 
organism for FHA studies. While TPS loci are typically arranged 5’-tpsB-tpsA-3’, the 
fha locus is arranged 5’-fhaB-fimA-fimB-fimC-fimD-fhaC-3’ (Locht et al., 1992; Cotter 
et al., 1998), with genes encoding components of fimbria biogenesis being located 
between fhaB and fhaC (Locht et al., 1992; Cotter et al., 1998). The locus is found 
next to the genes encoding the BvgAS two-component system, with the fhaB and 
bvgAS genes diverging. Expression of fhaB is regulated by BvgAS, with BvgS 
serving as the sensor-kinase and BvgA serving as the response regulator (Weiss et 
al., 1983; Miller et al., 1989; Cotter and Miller, 1994; Uhl and Miller, 1996; Jones et 
al., 2005). A low amount of phosphorylated BvgA is sufficient to initiate transcription 
of fhaB (Boucher et al., 1997; 2001). 
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The translated FhaB preproprotein (Figure 5) contains a 72 aa N-terminal 
signal peptide that contains an N-terminal extension of 22 aa (Lambert-Buisine et al., 
1998; Chevalier et al., 2004). C-terminal to the signal peptide is the ~250 aa TPS 
domain, which is required for secretion of FhaB across the outer membrane 
(Renauld-Mongenie et al., 1996; Clantin et al., 2004; Jacob-Dubuisson et al., 2004). 
C-terminal to the TPS domain is an ~1600 aa stretch of residues that become the β-
helical shaft of the mature protein (Makhov et al., 1994; Kajava et al., 2001; Clantin 
et al., 2004). The β-helix consists of two well defined repeat regions, R1 and R2, 
with repeats that differ in both sequence and predicted structure (Kajava et al., 2001; 
Kajava and Steven, 2006). FhaB of B. bronchiseptica (FhaBBb) contains 45 copies of 
the R1 repeat and 13 copies of the R2 repeat. Separating these regions is a so-
called carbohydrate recognition domain that contains an RGD motif and is predicted 
to form a β-helix of less-conserved repeats than the R1 or R2 regions (Relman et al., 
1989; 1990; Saukkonen et al., 1991; Prasad et al., 1993; Kajava et al., 2001). The 
stretch of polypeptide that will ultimately become the mature C-terminal domain 
(MCD) follows the β-helix (Makhov et al., 1994; Mazar and Cotter, 2006). Electron 
microscopy of negatively stained FHA molecules indicates that this domain is 
globular, although detail on the structure is lacking (Makhov et al., 1994). C-teriminal 
to the MCD is an ~1200 aa prodomain (Delisse-Gathoye et al., 1990; Mazar and 
Cotter, 2006). Towards the C-terminus of the prodomain is an ~200 aa proline-rich 
region of unknown importance (Locht et al., 1992; 1993). 
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Figure 5 
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The signal peptide targets nascent FhaB preproprotein to the general 
secretory system, which translocates the polypeptide across the inner membrane 
(Jacob-Dubuisson et al., 2004). Localization to the Sec system appears to be 
mediated by SecAB, suggesting that periplasmic translocation of FhaB occurs post-
translationally (Chevalier et al., 2004). Little is known about FhaB’s existence in the 
periplasm. When FHA44 (the N-terminal 80 kDa of FhaB) and FhaC are expressed 
in E. coli, FHA44 is unable to be recovered from the periplasm (Guedin et al., 1998), 
suggesting that FhaB begins transit through FhaC immediately upon exposure of the 
TPS domain to the POTRA domains. Furthermore, Guedin et al. showed that FHA44 
synthesized prior to FhaC expression cannot be released into the supernatant by 
live cells, though subcellular localization of FHA44 was not performed to determine 
the integrity of pre-fhaC-induction FHA44. It is likely that the FHA44 synthesized 
prior to fhaC expression was degraded, as FhaB is not detected in B. bronchiseptica 
whole cell lysates when FhaC is disrupted, suggesting that it is degraded in 
response to lack of secretion (Julio and Cotter, 2005). Collectively, these 
observations support a model for periplasmic transit of FhaB in which translocation 
across the inner and outer membrane is coupled and FhaB does not spend time in a 
soluble, periplasmic state. Alternatively, FhaB may be completely translocated into 
periplasm prior to recognition of the TPS domain by FhaC. Regardless of the model 
of periplasmic transit, recent studies have identified periplasmic chaperones that 
may be involved in ensuring that FhaB reaches FhaC (Hodak et al., 2008; Baud et 
al., 2009; 2011). These proteins may keep periplasmic FhaB unfolded while it 
transits across the outer membrane, suggesting that FhaB spends some appreciable 
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amount of time in the periplasm before extracellular translocation. These 
chaperones may also prevent aggregation of FhaB in the periplasm.  
 
The interaction between FhaB and FhaC is hypothesized to initiate 
translocation of FhaB across the outer membrane. The N-terminal TPS domain of 
the FhaB proprotein associates with the periplasmic POTRA domains of FhaC 
(Hodak et al., 2006) in vitro, suggesting that it also does so in vivo (Figure 6A). The 
TPS domain must be unfolded for this interaction. Far Western blotting 
demonstrated that the N-terminal 30 kDa of FHA (Fha30) only associates with FhaC 
when Fha30 is unfolded (Hodak et al., 2006). Pull-down assays confirmed that 
Fha30 in its native fold is unable to bind FhaC. Hodak et al. also conducted a 
systematic analysis of molecular determinants of the TPS domain for association 
with POTRA domains and secretion of Fha30, concluding that residues in the C1 
and C2 subdomains were critical for these processes. Similarly, a systematic 
analysis of FhaC’s two POTRA domains was performed, revealing residues required 
for recognition and secretion of the TPS domain by FhaC (Delattre et al., 2011). The 
current model of FhaB secretion is that this TPS-POTRA association causes 
conformational shifts in FhaC that expel H1 and L6, and in doing so clear the FhaC 
channel for FhaB secretion. The FhaC pore is 16 Å wide, though its occupation by 
H1 and L6 leaves even less room for FhaB secretion (Clantin et al., 2007). Given the 
40 Å width of folded FHA’s β-helix (Makhov et al., 1994), FhaB must transit the pore 
in an unfolded state (regardless of H1 and L6 occupation of the FhaC pore).  
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Figure 6 
 
Model of the FhaB/FhaC Two-Partner Secretion (TPS) system 
 
A. FhaB translocation across the Bordetella outer membrane. The FhaB 
preproprotein (labeled) is exported into the periplasm by the general secretory 
system (not shown). It is not known if the entire polypeptide is translocated into the 
periplasm before translocation through FhaC occurs. In this figure, the peptidoglycan 
layer and cytoplasmic membrane are not shown for simplicity. Also note that this 
figure was drawn to scale, as best as possible. Residue numbers of the FhaB 
proprotein are indicated. The FhaB TPS domain (orange) interacts with FhaC 
(purple) to initiate outer membrane translocation of FhaB as a hairpin. Upon 
extracellular exposure, the C-terminal portion of the TPS domain folds into a β-helix, 
nucleating folding of the β-helical shaft (blue) in an N- to C-terminal direction. At this 
point, FHA biogenesis could proceed by two routes, depending on the localization of 
the prodomain. The TPS domain remains associated with FHA after FHA release. 
B. Possibility that the prodomain remains intracellular. After the MCD (light green) 
has reached the cell surface, SphB1 (yellow) and an unidentified protease (dark 
green) cleave the intracellular prodomain (red) from FhaB and the prodomain is 
rapidly degraded. Mature FHA (labeled) can be either surface-associated or 
released. The mechanism for release is unknown. 
C. Possibility that the prodomain reaches the extracellular space. In this scenario, 
prodomain cleavage and degradation would both occur extracellularly. 
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Chimeric fusions of FHA44 and the globular B subunit of cholera toxin, CtxB, in E. 
coli indicate that the fusion protein is unable to be secreted when it is folded (Guedin 
et al., 1998). Only when the CtxB domain was unable to form intramolecular disulfide 
bonds was the chimeric protein able to be secreted. FhaB likely secretes through 
FhaC as an extended hairpin (Mazar and Cotter, 2006), with the N-terminus 
remaining associated with the POTRA domains while the downstream polypeptide 
transits through the pore of FhaC completely unfolded and as a hairpin (Figure 6A). 
Indeed, experimental evidence as to the topology of FHA demonstrates that the 
hairpin model of secretion is correct (Mazar and Cotter, 2006). 
 
During hairpin secretion of FhaB, the C-terminus of the TPS domain is the 
first portion of the protein to emerge into the extracellular space. The model states 
that upon emerging into the extracellular milieu, the TPS domain folds into a right-
handed β-helix (Kajava et al., 2001; Clantin et al., 2004) (Figure 6A). The source of 
energy to initiate secretion is unknown, as the periplasm has no ATP to drive 
secretion. It is thought that such folding nucleates the β-helical folding of C-terminal 
polypeptide as it crosses the outer membrane, thereby assembling an ~350 Å β-
helical shaft that extends away from the cell surface (Makhov et al., 1994; Kajava et 
al., 2001). The free energy provided by β-helical folding is hypothesized to pull the 
polypeptides of the MCD across the outer membrane (Mazar and Cotter, 2006). 
Complete folding of the β-helix is believed to draw the MCD into the extracellular 
space, where it is believed to fold into its functional conformation. After folding is 
complete, the FhaB proprotein is cleaved to generate mature FHA (Figure 6A). The 
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current model postulates that SphB1, a subtilisin-like autotransporter, is involved in 
cleavage of FhaB (Coutte et al., 2001; 2003). Although deletion of sphB1 in B. 
pertussis and B. bronchiseptica results in reduced processing of FhaB, SphB1 has 
not been shown to cleave FhaB directly (Coutte et al., 2001; Mazar and Cotter, 
2006). Furthermore, since deletion of sphB1 does not completely prevent 
maturation, it is clear that one or more SphB1-independent maturation determinants 
exist. The identities and mechanisms of these molecules, however, remain 
unknown. Cleavage of ~375 kDa FhaB results in separation of ~250 kDa mature 
FHA from the C-terminal ~130 kDa prodomain. The prodomain is not immuno-
detected as a stable, standalone polypeptide in Bordetella whole-cell lysates or 
supernatants, indicating that once it is cleaved from FhaB, it is quickly degraded 
(Delisse-Gathoye et al., 1990; Mazar and Cotter, 2006) (Figure 6A). When grown 
overnight in Stainer-Scholte media, Bordetella can both retain FHA on the outer 
membrane surface and release FHA into the media (Renauld-Mongenie et al., 1996) 
(Figure 6A). The mechanism regulating FHA retention is unknown, as are the in vivo 
functions of the surface-associated versus released forms of FHA. 
 
FHA function 
 
Although FHA is one of the primary components of acellular pertussis 
vaccines (Sato and Sato, 1999), an understanding of its role in virulence and host 
response is still incomplete. In vitro studies reveal a role for FHA in adherence to a 
variety of cell lines including lung epithelial cells and macrophages (Urisu et al., 
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1986; Tuomanen et al., 1988; Relman et al., 1989; 1990; Aricò et al., 1993; Locht et 
al., 1993; Cotter et al., 1998; Ishibashi et al., 2001). The VLA-5 receptor of 
mammalian cells and the CR3 and LRI/IAP receptors of macrophages have been 
proposed to be the receptors of FHA, with adhesion being mediated by an RGD 
motif found in the carbohydrate recognition domain of FHA (Relman et al., 1990; 
Ishibashi et al., 1994; 2001). In vivo studies indicate that FHA is required for 
colonization of the lower respiratory tract and persistence in the lungs (Cotter et al., 
1998; Inatsuka et al., 2005; Julio et al., 2009). Contrary to previous reports that 
emphasize the importance of the RGD motif, in vivo studies indicate that the RGD 
does not contribute to FHA-dependent pathogenesis (Julio et al., 2009). Rather, 
Julio et al. demonstrated that it is the MCD of FHA that is the primary determinant of 
FHA-mediated adherence in vitro and virulence in vivo. Furthermore, the FhaB 
prodomain affects FHA-dependent virulence, as prodomain truncations render B. 
bronchiseptica unable to adhere to lung epithelial cells or colonize the trachea of rats 
(Mazar and Cotter, 2006). 
 
FHA also exhibits immuno-modulatory properties. B. bronchiseptica in which 
fhaB has been deleted causes a hyper-inflammatory immune response in mouse 
lungs, much to the detriment of Bordetella persistence (Inatsuka et al., 2005). 
Specifically, FHA appears to regulate an IL-17-mediated immune response in mice, 
as deletion of fhaB results in an early influx of IL-17-postive neutrophils, 
macrophages and CD4+ T cells (Henderson et al., 2012). As mentioned earlier, FHA 
is both surface-associated and released. Whether either or both of these forms are 
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functional in vivo, and precisely what those functions are, remain among the greatest 
challenges to understanding the role of FHA in virulence. In vitro studies suggest 
that the released form of FHA may affect cell signaling to down-regulate IL-12 
production in macrophages (McGuirk and Mills, 2000). Purified FHA has also been 
implicated in affecting NF-κB and interferon responses in vitro (Abramson et al., 
2008; Dieterich and Relman, 2011). 
 
FHA in Bordetella pertussis 
 
B. pertussis is a human-specific pathogen and B. pertussis research is 
hampered due to the lack of a good animal model of infection. B. bronchiseptica 
infects a broad range of mammalian hosts, and in vivo work done using B. 
bronchiseptica is conducted in hopes that it will translate well into our understanding 
of B. pertussis virulence. In the case of FHA specifically, FhaBBb and the FhaB of B. 
pertussis (FhaBBp) are functionally interchangeable (Julio et al., 2009), validating 
studies of FhaB in B. bronchiseptica. Although functionally interchangeable, there 
are a handful of differences between the two proteins. Alignment of amino acid 
sequence of FhaBBb and FhaBBp reveals that FhaBBp has fewer repeats in the R1 
region of the β-helix – 39 compared to 45 for FhaBBb (Kajava et al., 2001). The 
MCDs of FhaBBb and FhaBBp are ~93.5% identical, likely accounting in large part for 
functional interchangeability of the two proteins. The prodomains of the two proteins 
are also very highly conserved. Two regions differ between the B. bronchiseptica  
and B. pertussis prodomains – both in the proline-rich region. The first difference is 
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residues 3442-3454 of B. bronchiseptica, which share little similarity to their 
corresponding region of the B. pertussis FhaB prodomain (3330-3342 of B. 
pertussis). The second difference is a (PA)6(PK)4 motif towards the end of the B. 
bronchiseptica PRR that is instead a (PK)5 motif in B. pertussis. FhaBBp undergoes 
maturation proteolysis to a greater extent than FhaBBb (Mazar and Cotter, 2006). As 
previously mentioned, SphB1 is one of the proteases implicated in FhaB maturation 
cleavage and FhaBBb and FhaBBp differ in their SphB1-dependent cleavage. 
Generally speaking, FhaB is processed into four isoforms, with the three smaller 
isoforms (FHA, FHA1, and FHA2) being cleaved in the same site in B. bronchiseptica 
and B. pertussis (Mazar and Cotter, 2006). The cleavage site of the larger isoform, 
however, differs between the two strains. The cleavage site of the largest B. 
pertussis isoform, FHA*, is located C-terminal that of B. bronchiseptica, FHA′ (Mazar 
and Cotter, 2006). When FhaBBb is expressed in B. pertussis, SphB1-dependent 
cleavage of FhaBBb occurs at the same sites as it does in B. bronchiseptica (Julio et 
al., 2009), indicating that the site of maturation cleavage is determined by the 
peptide sequence rather than the strain background. In B. pertussis, SphB1-
dependent FhaB maturation yields virtually no full-length FhaBBp in whole-cell 
lysates. SphB1-dependent processing is less efficient in B. bronchiseptica, where 
appreciable levels of full-length FhaBBb detected in whole-cell lysates (Mazar and 
Cotter, 2006). When FhaBBb is expressed in B. pertussis, full-length FhaBBb is 
detected at a level that is in between that of FhaBBp in B. pertussis and FhaBBb in B. 
bronchiseptica (Julio et al., 2009). Furthermore, B. pertussis releases much more 
FHA than B. bronchiseptica (Jacob-Dubuisson et al., 2000; Mazar and Cotter, 2006; 
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Julio et al., 2009). Similar to the case of SphB1-dependent processing, B. pertussis 
producing FhaBBb releases mature FHABb at a level in between FHABp in B. pertussis 
and FHABb in B. bronchiseptica (Julio et al., 2009). Collectively, the data presented 
by Julio et al. indicates that both strain background and polypeptide sequence are 
determinants of FhaB processing thoroughness and FHA release levels. 
 
FhaB homologues in Bordetella 
 
FhaB is not the only TPS system present in Bordetella. Two FHA-like 
proteins, FhaS and FhaL, are also encoded in the genome of B. bronchiseptica and 
B. pertussis. FhaL has not been functionally or molecularly characterized, but some 
work has been done to characterize FhaS. Expression of the fhaS gene is under the 
control of the BvgAS two-component regulatory system, though maximal expression 
does not appear to be regulated by phosphorylated BvgA in the same manner by 
which fhaB expression is regulated (Julio and Cotter, 2005). A standout difference 
between FhaSBb and FhaBBb is the absence of a 28 residues towards the C-terminus 
of the MCD in FhaS. B. bronchiseptica in which these 28 residues are deleted from 
FhaB is able to adhere to L2 and macrophage-like cells, but is unable to colonize the 
trachea of rats (Julio et al., 2009). Furthermore, this deletion mutant induces a 
hyper-inflammatory response in the lungs of infected mice. Additionally, the FhaS 
prodomain is missing the proline-rich region found in FhaB. Functionally, FhaS 
remains largely mysterious. Deletion of fhaS from B. bronchiseptica does not result 
in defective adherence to L2 and BEAS-2B cells (Julio and Cotter, 2005). The ΔfhaS 
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strain also appears to have no defect in tracheal colonization of rats. When rats are 
co-infected with wild-type B. bronchiseptica and the fhaS strain, however, the 
number of CFUs recovered for the mutant strain is lower than those of the wild-type 
strain, indicating that FhaS does indeed contribute to bacterial fitness in vivo in a 
manner that cannot be complemented by wild-type Bordetella in a wild-type/ΔfhaS 
co-infection. 
 
Outstanding Questions 
 
An initial impression of FHA might be that it is a fairly straightforward protein – 
a very long β-helical shaft with a distal adhesive tip. These impressions are indeed 
consistent with data collected on FHA, but they overlook a prominent feature of 
FhaB – its ~130 kDa prodomain. Since it was first described as a part of the FhaB 
proprotein, researchers have hypothesized that it functions as an intramolecular 
chaperone, keeping FhaB in an unfolded state in order to prevent aggregation and 
keep FhaB secretion-competent (Delisse-Gathoye et al., 1990). Mazar and Cotter, 
however, demonstrated that FhaB could be secreted by strains that contained a 
variety of FhaB prodomain truncations (Mazar and Cotter, 2006), indicating that the 
prodomain did not chaperone the proprotein the FhaC. Even so, truncations of the 
prodomain resulted in adherence defects in vitro and colonization defects in vivo, 
showing that the prodomain serves a critical role in FHA functionality. What that role 
is, though, remains unknown. Furthermore, although previous models of FhaB 
secretion indicate that the prodomain remains in an intracellular compartment 
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(Figure 6B), its fate is unknown and it may very well function in the extracellular 
space (Figure 6C). 
 
In addition to its enormous size, a standout feature of the FhaB prodomain is 
a ~200 aa proline-rich region at the prodomain C-terminus (Locht et al., 1992; 1993). 
For a subdomain of such unusually high proline content, it is surprising that no 
research has been performed to reveal its contribution to FHA biogenesis and 
function. Of further interest is what other subdomains exist within the ~1200 aa 
prodomain, and what their contributions are. 
  
 
Chapter II – The FhaB prodomain affects the conformation of the MCD 
 
Bioinformatic analysis of the FhaB prodomain 
 
A PSI-BLAST search using the entire B. bronchiseptica FhaB prodomain as 
query revealed substantial similarity over the entire length of the prodomain (E-
values ≤ e-30) with other FHA-related proteins in Bordetella species as well as a few 
related proteins in Pasteurella multocida, Haemophilus ducreyi, Citrobacter 
rodentium and Erwinia billingiae. Strikingly, however, hundreds of predicted TpsA 
proteins, many of which are known to belong to the FHA subfamily, were identified 
with significant similarity (alignment scores between 80 and 200) to residues 2472-
2601 of the FhaB prodomain, which we are now calling the prodomain N-terminus 
(PNT). ClustalW analysis revealed ~50% similarity overall among the proteins 
identified in our analysis (Figure 7). No similarity with other proteins above the 
threshold level set by PSI-BLAST was identified for regions of the FhaB prodomain 
C-terminal to the PNT. We did, however, notice a proline-rich region near the C-
terminus of the prodomain by simple visual examination of the amino acid sequence. 
This proline-rich region has been noted previously (Antoine and Locht, 1992; Locht 
et al., 1992) and, curiously, a putative FHA orthologue in Bordetella avium contains 
a region with even more prolines near its C-terminus. There are no reports of 
functional characterization for any sequences with which similarity with the
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Figure 7 
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At the top is a schematic of B. bronchiseptica FhaB showing domain locations. At the 
bottom, WebLogo 3.1 display of homology shared amongst TpsA proteins to the 
~125 aa B. bronchiseptica FhaB prodomain N-terminus (PNT). The species (and 
accessions) included in the ClustalW alignment are A. radiobacter 
(YP_002542793.1), B. bronchiseptica (NP_889529.1), B. grahamii 
(YP_002971785.1), B. henselae (YP_033492.1), B. parapertussis (NP_885212.1), 
B. pertussis (NP_880571.1), E. billingiae (YP_003741557.1), E. cancerogenous 
(ZP_05970215.2), E. coli UTI 89 (YP_543880.1), F. gonidiaformans 
(ZP_05631037.1), F. nucleatum (NP_602617.1), F. varium (ZP_04859779.1), H. 
ducreyi (NP_873911.1), H. somnus (YP_001784809.1), L. hofstadii 
(ZP_05902926.1), P. dagmatis (ZP_0592026.1), P. fluorescens (YP_257313.1), P. 
multocida (NP_244996.1), P. vagans (YP_003931455.1), R. leguminosarum 
(YP_002278042.1), Shigella sp. D9 (ZP_05433039.1), S. aggregata 
(ZP_01545092.1), S. termitidus (YP_003310063.1), V. cholerae (ZP_01955515.1), 
V. coralliilyticus (ZP_05888559.1), V. mimicus (ZP_05718784.1), X. oryzae 
(YP_001915776.1), Y. frederiksenii (ZP_046344430.1), Y. intermedia 
(ZP_04636695.1), Y kristensenii (ZP_04622797.1)
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prodomain was identified. 
 
The conformation of purified MCD is affected by the prodomain 
 
Because the prodomain is required for FHA function in vivo (Mazar and 
Cotter, 2006) and there is evidence that the MCD is an important functional domain 
(Julio et al., 2009; Henderson et al., 2012), we hypothesized that the FhaB 
prodomain is required for the MCD to attain its proper conformation. To test this 
hypothesis, two B. pertussis strains were constructed that produce FhaB proteins 
containing hexahistidine (His6) insertions immediately C-terminal to Q72 (the N-
terminal amino acid of mature FHA) and tobacco etch virus (TEV) protease cleavage 
sites at the junction between the β-helical shaft and the MCD. One strain (BPSMAQ) 
produced full-length FhaB and the other (BPSMAQT-N) contained a stop codon in 
fhaB 48 codons 3′ to the region encoding the primary SphB1-dependent cleavage 
site (Figure 8A – note that residue numbering of the schematic corresponds to B. 
pertussis FhaB, not B. bronchiseptica FhaB). We used B. pertussis strain BPSM for 
these experiments because it releases substantially more FHA into culture 
supernatants than B. bronchiseptica strain RB50, facilitating our ability to recover a 
sufficient amount of protein with minimal manipulation (Jacob-Dubuisson et al., 
2000; Mazar and Cotter, 2006). The presence of the His6 tag and the TEV protease 
cleavage site did not affect the ability of otherwise wild-type FHA to function as an 
adhesin in vitro (Figure 8B). Bacteria were grown under fhaB-inducing conditions, 
and culture supernatants were collected under native conditions and incubated with  
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Figure 8 
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Figure 8 
 
The FhaB prodomain affects the conformation of the MCD 
 
A. At top is an illustration of mature FHA with an N-terminal hexahistidine tag and a 
TEV protease cleavage site upstream of the MCD. Below are schematics of the B. 
pertussis FhaB proteins as initially synthesized. From left, the domains illustrated are 
the signal peptide (purple), the TPS domain (orange), the β-helical shaft (light blue), 
the MCD (green), the PNT (dark red), and the remainder of the prodomain (red). The 
hexahistidine tag is located between the signal peptide and the TPS domain. The 
TEV protease cleavage site is located between the β-helix and the MCD. The 
approximate site of SphB1-dependent cleavage is noted. The proline-rich region 
(PRR) of the prodomain is also noted. Residue numbering is based on the B. 
pertussis FhaB protein. 
B. The strains were tested to determine if the hexahistidine tag and TEV protease 
site altered FHA-mediated adherence to A549 human lung epithelial cells. BPSMAQ 
adhered in a manner indistinguishable from wild-type B. pertussis, while BPSMAQT-
N adhered as inefficiently as an fhaB deletion strain. 
C. Anti-MCD immunoblot of purified MCD polypeptides. Semi-native gel analysis 
indicated altered mobility of the MCD derived from the prodomain-truncated (T-N) 
FhaB compared with the MCD derived from full-length (AQ) FhaB. When denatured 
by either heat or chemical denaturation, the MCDs of both proteins migrate 
identically. 
D. Western blot of MCD polypeptides after proteinase-K treatment. Purified MCDs 
were tested for sensitivity to proteinase-K. Samples were incubated with increasing 
concentrations of proteinase-K, separated by SDS-PAGE, and detected with anti-
MCD antibody. Additionally, samples were denatured/renatured prior to analysis of 
proteinase-K sensitivity. Densitometry values proportionate to the undigested 
sample of each Western blot are listed below the blots. 
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nickel-chelating resin, which was then washed and incubated with AcTEV protease  
to release the MCD from FHA. The MCD polypeptides were resolved on a semi-
native polyacrylamide gel (0.6% SDS).  
 
Samples were then transferred to a nitrocellulose membrane and probed with 
anti-MCD antibody. The MCD polypeptides recovered from the BPSMAQ and 
BPSMAQT-N strains under native conditions migrated with different mobilities on the 
semi-native gel, but they migrated with the same mobility after heat denaturation 
(Figure 8C). The MCD polypeptides migrated with the same mobility regardless of 
pre-heating when separated by standard, denaturing, SDS-PAGE (2.0% SDS). 
These results suggest that the presence of the prodomain in the nascent FhaB 
polypeptide affects the conformation of the MCD in mature FHA. 
 
We also treated the native MCD polypeptides with increasing concentrations 
of proteinase-K and resolved them by SDS-PAGE. While the MCD from BPSMAQ 
(which produces full-length FhaB) was completely digested by 12 µg/mL of 
proteinase-K, 50 µg/mL of proteinase-K was required to completely degrade the 
MCD from BPSMAQT-N (Figure 8D). As a control, the MCDs from both strains were 
boiled to denature the proteins, then allowed to renature, and were then incubated 
with proteinase-K. After being subjected to denaturing and renaturing conditions in 
vitro, both MCD polypeptides were completely degraded by 25 µg/mL proteinase-K, 
suggesting that the conformations of the in vitro renatured proteins were the same 
(but different from those of the naturally folded polypeptides, which were digested by 
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either 25 or 50 µg/mL proteinase-K). Together, these data indicate that the 
conformation of the MCD that forms after translocation to the bacterial surface differs 
depending on whether the initially synthesized FhaB protein contains the C-terminal 
prodomain. 
 
The conformation of the MCD of mature FHA is affected by the prodomain 
 
As an additional approach to probe the conformation of the MCD, we 
performed cysteine-accessibility experiments, taking advantage of the fact that FHA 
contains no cysteine residues. We constructed a series of B. bronchiseptica strains 
– in both wild-type (WT) and prodomain-truncated (ΔPD) backgrounds – in which a 
single codon in the MCD-encoding region of fhaB was changed to a cysteine codon 
(Figure 9A), with substitutions regularly spaced ~50 aa apart. (We used B. 
bronchiseptica for these experiments so that the mutant strains could subsequently 
be compared with wild-type bacteria for their ability to establish respiratory infections 
in natural-host animal models.) The strains shown in Figure 9 are those that grew 
and adhered to L2 rat lung epithelial cells in a manner indistinguishable from wild-
type B. bronchiseptica (data not shown) and they released FHA as efficiently as 
wild-type bacteria. Culture supernatants were concentrated under native conditions 
and incubated with DyLight 680 Maleimide, which forms a covalent bond with the 
sulfhydryl group on cysteine residues. Samples were then separated by SDS-PAGE, 
transferred to a nitrocellulose membrane, and probed with an antibody that 
recognizes a central region of FHA [the carbohydrate recognition domain (CRD)] to  
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Figure 9 
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The FhaB prodomain affects the surface-accessibility of MCD residues
A. Schematic of B. bronchiseptica FhaB cysteine-substitution proteins. Single 
cysteine residues were substituted into wild-type (WT) and prodomain-truncated 
(DPD) proteins.
B. Cysteine-accessibility immunoblot of FHA recovered under native conditions from 
culture supernatants. The Western blots were immuno-stained with an anti-CRD 
antibody (green) and displayed four isoforms of mature, released FHA. Native FHA 
	   42	  
determine the relative amounts of FHA contained in each sample. The anti-CRD 
antibody was detected with anti-chicken antibody conjugated to a near-infrared dye 
that fluoresces at 800 nm, shown in green in Figure 9B. The fluorophore of the 
DyLight 680 Maleimide fluoresces at 680 nm, shown in red in Figure 9B. For the 
A2382C substitution, and to a lesser extent, the A2432C substitution, FHA produced 
in the wild-type strain displayed greater DyLight-dependent fluorescence than FHA 
produced in the ΔPD strain, indicating that these cysteines were more accessible in 
the FHA produced by the wild-type strain than in the FHA produced by the ΔPD 
strain (Figure 9B). Conversely, for the V2081C, L2284C and I2233C substitutions, 
FHA produced by the wild-type strain displayed weaker fluorescence than FHA 
produced by the ΔPD strain. These data indicate that the accessibility of the cysteine 
residues differed depending on whether FhaB contained an intact prodomain and 
therefore provide further support for the conclusion that the prodomain affects the 
conformation of the MCD. 
 
Chapter III – The FhaB prodomain mediates its own intracellular localization 
 
The C-terminus of the prodomain remains in an intracellular compartment 
 
We envisaged three mechanisms by which the FhaB prodomain could affect 
the conformation of the MCD on mature FHA: (i) the prodomain could function as a 
scaffold or ‘foldase’ for the MCD, analogous to the prodomains of many secreted 
proteases of Gram-positive bacteria (Shinde and Thomas, 2011); (ii) the prodomain 
could remain in an intracellular compartment, functioning as a tether to constrain the 
possible conformations that the MCD can sample before attaining a stably folded 
state; (iii) the prodomain could control the rate of translocation of the MCD to the cell 
surface and that controlled translocation could be required for proper folding (e.g. 
perhaps the N-terminal region needs to fold first, followed by the C-terminal region). 
In the first mechanism, the entire prodomain would be translocated to the cell 
surface before subsequent maturation (assuming that a fully folded MCD cannot be 
translocated through FhaC) while in the second and third mechanisms, the C-
terminus of the prodomain would remain in an intracellular compartment. We 
therefore sought to determine the location of the prodomain during maturation of 
FHA. We were specifically interested in determining the location of the C-terminus of 
the prodomain before cleavage of FhaB to form FHA. 
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We first constructed a B. bronchiseptica strain (CTHA) producing FhaB with a 
hemagglutinin (HA) epitope seven residues N-terminal to the C-terminus of FhaB 
(Figure 10A). Immunoblot analysis indicated that the HA epitope disrupted the 
stability of full-length FhaB [no full-length FhaB protein was detected in this strain by 
either the anti-MCD or anti-HA antibodies (Figure 10B)], rendering the strain 
unsuitable for localization studies. We therefore constructed a B. bronchiseptica 
strain (HAPRR) producing FhaB with an HA epitope after residue 3265, just N-
terminal to the proline-rich region in the FhaB prodomain (Figure 10A). This epitope 
did not affect secretion, maturation or release of FhaB, as the proportion of FhaB 
and FHA polypeptides was indistinguishable between this strain and wild-type 
bacteria (Figure 10B). Moreover, preliminary data suggest this strain is 
indistinguishable from wild-type B. bronchiseptica in its ability to cause respiratory 
infection in mice (our unpublished results). 
 
To determine if the prodomain remains in an intracellular location, the HAPRR 
strain was grown under FHA-inducing conditions, cells were harvested by 
centrifugation and suspended in buffer with 1 µg/mL proteinase-K to cleave surface-
exposed proteins, washed to remove extra-cellular protein fragments, then whole-
cell lysates (whole-cell lysates) were prepared and analyzed by immunoblot (Figure 
11B. Note that the left and right panels in Figure 11B are the same immunoblot. The 
intensity of the red channel was increased in the panel on the right to facilitate 
visualization of polypeptides detected by the anti-HA antibody. Similar manipulation 
of the green channel did not reveal any additional bands). In the untreated sample,  
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A. Schematic of FhaB proteins used in experiment. Domain layout is the same as 
that of Figure 4. The PRR in front of which the HA tag was introduced is labeled for 
the HAPRR strain.
B. Anti-MCD (green) and anti-HA (red) immunoblot of whole-cell lysates and concen-
trated supernatants. Introducing an HA tag at the C-terminus of FhaB causes insta-
bility of full-length FhaB. Moving the epitope upstream of the PRR does not affect 
the integrity or maturation of full-length FhaB. FHA release into the supernatants is 
unaffected by either location of the HA tag.
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A. Schematic of B. bronchiseptica HA-tagged FhaB protein used in proteinase-K 
digestion experiments. The site of the HA tag is noted. An HA tag was also intro-
duced to a ΔsphB1 background.
B. Left, anti-MCD (green) and anti-HA (red) immunoblot of proteinase-K treated 
whole-cells, lysed to evaluate cellular protein content. PMSF was added prior to 
proteinase-K incubation as indicated. The panel on the right is an analysis of the 
immunoblot on left, with the intensity of the 700 nm (anti-HA) channel increased for 
visualization of proteinase-K dependent intracellular prodomain. Bottom, anti-BvgS 
immunoblot of whole-cell lysates.
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full-length, unprocessed FhaB (~375 kDa) was detected by both anti-MCD and anti- 
HA antibodies and mature FHA (FHA and FHA′, ~250 kDa) was detected by only the 
anti-MCD antibody. Some polypeptides of ~200 kDa were also detected by the anti-
HA antibody (evident in the right panel), suggesting they result from proteolysis near 
the N-terminus of FhaB. Since FHA is anchored to the cell surface by its N-terminus, 
we hypothesize that these polypeptides result from proteolysis during sample 
preparation. Consistent with previous results indicating that the prodomain is 
degraded rapidly after FhaB processing (Delisse-Gathoye et al., 1990; Mazar and 
Cotter, 2006), no polypeptide of ~130 kDa was recognized by the anti-HA antibody 
in the untreated samples. Proteinase-K treatment caused a decrease in the amount 
of full-length FhaB (and mature FHA) and PMSF inhibited this proteolysis, indicating 
that this proteolysis was proteinase-K-dependent. Concomitant with the proteinase-
K-dependent decrease in FhaB was the appearance of polypeptides of ~230 kDa 
that were recognized by only the anti-MCD antibody (green channel) and 
polypeptides of ~120-140 kDa that were recognized by only the anti-HA antibody 
(Figure 11B, red channel in the right panel). Proteinase-K activity was confined to 
the extracellular space, as indicated by the integrity of BvgS, a sensor kinase that 
spans the cytoplasmic membrane and contains a large periplasmic domain. The 
~230 kDa polypeptide that predominates after proteinase-K treatment is most likely 
the N-terminus and β-helical shaft region of FHA, consistent with β-helical proteins’ 
resistance to proteinase-K (Ieva and Bernstein, 2009; Julio et al., 2009). The 
appearance of cell-associated HA-containing polypeptides of ~120-140 kDa after 
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proteinase-K treatment, but not before proteinase-K treatment, suggests that they 
arose from polypeptides in which the C-terminus of the prodomain was intracellular  
while the central region of FhaB (most of the β-helical shaft, the MCD, and perhaps 
the N-terminus of the prodomain) was extracellular. In the ΔsphB1 strain, more 
polypeptides in the range of ~120-160 kDa were recognized by the anti-HA antibody 
in the proteinase-K treated sample than in the proteinase-K treated sample of the 
strain that is wild-type for sphB1 (Figure 11B, right). These data suggest that the C-
terminus of the prodomain remains in an intracellular compartment during outer 
membrane translocation of the β-helix and MCD regions, but these data cannot 
distinguish between periplasmic versus cytoplasmic localization of the prodomain C-
terminus.  
 
The region surrounding FhaB maturation sites is required for the C-terminus of the 
prodomain to remain in an intracellular compartment and for mature FHA to be 
released from the cell surface 
 
Although the data shown in Figure 11 suggest an intracellular location for the 
FhaB prodomain, the experiment is complicated by the fact that FhaB is processed 
by both SphB1 and one or more unidentified proteases, making it difficult to ‘capture’ 
the pre-cleavage FhaB secretion intermediate. In an attempt to eliminate both 
SphB1-dependent and SphB1-independent processing, we constructed a strain (HA-
ΔCS) producing an FhaB protein with a 431 aa deletion encompassing the known 
SphB1-dependent cleavage sites and the region that becomes the C-terminus of 
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FHA′, which is produced by cleavage/degradation by the unidentified protease(s). 
The FhaB produced by this strain contains an HA epitope N-terminal to the PRR, the 
same as in the HAPRR strain (Figure 12A). Unprocessed FhaB in the HA-ΔCS strain 
was smaller than FhaB in wild-type bacteria (consistent with the size of the deletion) 
and was detected with both anti-MCD and anti-HA antibodies [(Figure 12B, band 5). 
Illustrations to the right of Figure 12B illustrate how we envision FhaB/FHA exist on 
the cell surface with and without proteinase-K treatment. Band numbers on the 
Western blot correspond to illustration numbers]. Unexpectedly, FhaB was still 
processed in this strain, resulting in the formation of polypeptides of ~250 and ~220 
kDa [Figure 12B, bands 6 (green)] that were detected only by the anti-MCD antibody 
and therefore represent the N-terminal ~2300-2500 aa of FhaB. Processing to form 
these polypeptides did not occur in a strain that was isogenic except for deletion of 
sphB1 (referred to as HA-ΔCS,ΔsphB1), indicating that the processing was SphB1-
dependent (Figure 12B). (Note, however, that this strain contained an increased 
amount of FhaB in whole-cell lysate and many breakdown products were present 
that were recognized by the anti-HA antibody and therefore resulted from 
degradation from the N-terminus of FhaB, presumably during sample preparation.) 
Proteinase-K treatment of the HA-ΔCS strain resulted in cleavage of FhaB and FHA 
(Figure 12B, band 7), but no polypeptides recognized by the anti-HA antibody were 
generated that could be detected in whole-cell lysate. This result suggested that, in 
contrast to the case of wild-type bacteria, the C-terminus of the prodomain was not 
retained intracellularly in the HA-ΔCS strain. Comparison of proteins present in 
culture supernatants showed that wild-type and ΔsphB1 bacteria released FHA and  
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Figure 12 
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Figure 12 
 
The region surrounding the native SphB1-dependent cleavage site regulates FHA 
release and keeps the C-terminus of the prodomain intracellular 
 
A. Schematic of proteins used in proteinase-K digestion experiments. The ΔCS 
mutation was also made in a ΔsphB1 background. 
B. Top, anti-MCD (green) and anti-HA (red) immunoblot of whole-cell lysate of the 
cleavage-site deletion strain. Cells were incubated with proteinase-K as indicated. 
PMSF was added prior to proteinase-K incubation as indicated. Numbers above 
protein bands correspond to illustrations on the right side of the figure. Illustrations 1-
4 represent products of the HAPRR strain, while illustrations 5-9 represent products 
of the HA-ΔCS strain. These illustrations show how we envision FhaB/FhaC exist at 
the outer membrane (OM, gray), with the area above the OM representing the 
extracellular space and the region below the OM representing the intracellular 
space. Proteinase-K is colored orange. Illustrations are not drawn to scale. Bottom, 
anti-BvgS immunoblot of whole-cell lysates.  
C. Anti-MCD (green) and anti-HA (red) immunoblot of concentrated supernatants. 
Samples were run on an 8% polyacrylamide gel to resolve the released forms of 
FHA and prodomain.  
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FHA′, respectively, and did not release HA-containing polypeptides into the 
extracellular environment (Figure 12C). By contrast, the HA-ΔCS strain released a 
large amount of HA-containing polypeptides of about 50-80 kDa, but released no 
mature FHA into the culture supernatant. (Proteins were separated using an 8% 
polyacrylamide gel for the immunoblot shown in Figure 12C, which allows lower 
molecular weight proteins to be visualized, but limits resolution of higher molecular 
weight proteins.) The prodomain, therefore, appears to not be retained intracellularly 
in the HA-ΔCS strain and not only are prodomain polypeptides released into the 
culture supernatant, they are relatively stable. In the HA-ΔCS,ΔsphB1 strain, FhaB 
remained predominantly unprocessed, as whole-cell lysate contained mostly full-
length FhaB and several breakdown products, but no polypeptides corresponding to 
FHA. Proteinase-K treatment of the HA-ΔCS,ΔsphB1 strain resulted in the formation 
of a predominant polypeptide of about 220 kDa that was recognized by the anti-MCD 
antibody but not the anti-HA antibody (Figure 12B, band 9), therefore corresponding 
to the β-helical shaft and part of the MCD. No HA-containing polypeptides were 
released into the culture supernatant of the HA-ΔCS,ΔsphB1 strain, consistent with 
the conclusion that processing of FhaB does not occur in this strain and that the HA-
containing polypeptides present in the supernatants of the HA-ΔCS strain were 
extracellularly located prodomain fragments released after SphB1-dependent 
processing. Together, these data indicate that sequences within the region deleted 
in the HA-ΔCS strain are required for retention of the C-terminal region of the 
prodomain in an intracellular compartment and are also required for release of 
mature FHA into the extracellular environment. Although some degradation of BvgS 
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by proteinase-K was evident in this experiment, indicating that some amount of 
proteinase-K entered the cells, the presence of large amounts of HA-stained 
polypeptides of ~75 kDa in supernatants of the HA-ΔCS strain, but no HA-containing 
polypeptides in supernatants of wild-type B. bronchiseptica, strongly suggests that 
the prodomain is retained in an intracellular compartment in wild-type bacteria but 
not in HA-ΔCS bacteria. Complete elimination of HA-containing polypeptides in the 
HA-ΔCS,ΔsphB1 strain after proteinase-K treatment also supports this conclusion. 
 
As an alternate approach, we performed dot blots of the HAPRR and HA-ΔCS 
strains (Figure 13). Whole cells in PBS were applied to a nitrocellulose membrane 
for detection of surface antigens and boiled lysates were applied to the membrane 
for detection of total cellular protein content. Whole cells of the HAPRR strains 
(sphB1WT and ΔsphB1 backgrounds) were stained by only the anti-MCD antibody 
(Figure 13B; note that the schematics below the dot blots indicate only the various 
polypeptide species, not their relative abundances). Boiling the samples however, 
allowed detection by both the anti-MCD and anti-HA anti-bodies, indicating that the 
C-terminus of the prodomain in the HAPRR strains was located intracellularly. In the 
HA-ΔCS strain (sphB1WT), there was no surface detection of HA epitopes, consistent 
with the previous result indicating SphB1-dependent cleavage and release of a 
surface-localized prodomain in this strain. Boiling the sample resulted in weak 
detection of the HA tag, which we hypothesize represents FhaB molecules prior to 
translocation across the outer membrane. In the HA-ΔCS,ΔsphB1 strain, detection 
of both surface proteins and cell lysate revealed MCD and HA epitopes, consistent  
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Figure 13 
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Figure 13 
 
The prodomain C-terminus of full-length FhaB remains intracellular 
 
A. Schematic of proteins used in dot blot experiments. The ΔCS mutation was also 
made in a ΔsphB1 background. 
B. At the top, anti-MCD (green) and anti-HA (red) immuno-dot-blot of HAPRR and 
HA-ΔCS strains. Normalized amounts of whole cells and boiled lysates were 
applied. Below, illustrations of immuno-stained samples. The rounded gray rectangle 
represents the B. bronchiseptica outer membrane, with a solid edge representing the 
outer membrane of an intact cell and a dashed edge representing an outer 
membrane disrupted by boiling. MCD staining is represented by green-circled 
antibodies and HA staining is represented by red-circled antibodies. 
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with idea that the prodomain crossed the outer membrane, but was not cleaved in 
the absence of SphB1. [Note: The Western blot in Figure 12B indicates that some 
full-length, surface-exposed FhaB is present in the HA-ΔCS,sphB1WT strain (band 
5). Although very faint staining of this strain by the anti-HA antibody was apparent in 
some dot blot experiments, it is not apparent in the one shown in Figure 13B. Lack 
of significant staining by dot blot compared with Western blot may be due to 
differences in sample preparation and differences in sensitivity of the two assays.] 
As a control, a B. bronchiseptica strain without an HA tag in FhaB (RBX11) was 
used in an identical experiment. Although both whole cells and boiled lysates were 
recognized by the anti-MCD antibody, neither were recognized by the anti-HA 
antibody (Figure 14B), demonstrating that there was no nonspecific fluorescence in 
our samples probed with the anti-HA antibody. Taken together, these data indicate 
that the C-terminus of the prodomain is retained in an intracellular compartment 
(either the periplasm or the cytoplasm) during translocation and maturation of FHA 
and that the prodomain is degraded rapidly after SphB1-dependent and/or SphB1-
independent processing when retained intracellularly. Sequences within the region 
deleted in the HA-ΔCS strain are required for the C-terminus of the prodomain to 
remain intracellular and for mature FHA to be released from the cell surface. 
 
The C-terminus of the MCD controls FHA release competency while the N-terminus 
of the prodomain controls intracellular prodomain retention 
 
To investigate which sequences within the region deleted in the HA-ΔCS 
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Figure 14 
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strain were responsible for retention of the prodomain in an intracellular 
compartment and for release of mature FHA, we constructed strains producing FhaB  
proteins with either a 255 aa deletion of the MCD C-terminus (the MCT, shaded dark 
green in Figure 15) or a 176 aa deletion of the prodomain N-terminus (the PNT, 
shaded dark red). These strains, which contain the sequence encoding an HA 
epitope just 5′ to the PRR-encoding region, were named HA-ΔMCT and HA-ΔPNT, 
respectively. The ΔPNT deletion encompasses the primary SphB1-dependent 
cleavage site (the sequence of which is PLFETRIKFID). 
 
Immunoblot analysis (resolved by 5% polyacrylamide SDS-PAGE) showed 
that both unprocessed and processed FhaB/FHA polypeptides were detectable in 
whole-cell lysate of the HA-ΔMCT strain (Figure 15B, bands 8 and 9, respectively. 
Bands of the Western blot and illustration are labeled as in Figure 12B). In addition, 
a polypeptide of ~150 kDa that was recognized by both anti-MCD and anti-HA 
antibodies (Figure 15B, band 10), as well as a few slightly smaller polypeptides, was 
detected. Recognition of the ~150 kDa polypeptide by both antibodies indicates that 
it includes the prodomain and at least part of the MCD. These polypeptides were not 
detected in whole-cell lysate of the HA-ΔMCT strain that also contained the ΔsphB1 
deletion, demonstrating that they resulted from SphB1-dependent cleavage. The fact 
that analogous polypeptides are not present in the HAPRR strain suggests that 
SphB1-independent cleavage/degradation of the prodomain is inefficient in the HA-
ΔMCT strain, since SphB1-independent cleavage would have separated the MCD 
part of the polypeptide from the C-terminus. The presence of these polypeptides in  
	   59	  
Figure 15 
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Figure 15 
 
The MCT controls FHA release and the PNT keeps the prodomain C-terminus 
intracellular 
 
A. Schematic of FhaB proteins used in experiment. The MCT is represented as dark 
green. Mutations were also made in a ΔsphB1 background. 
B. Anti-MCD (green) and anti-HA (red) immunoblot of whole-cell lysates. Numbers 
above protein bands correspond to illustrations on the right side of the figure. 
Illustrations 1-4 represent products of the HAPRR strain, 5-7 represent products of 
the HA-ΔCS strain, 8-12 represent products of the HA-ΔMCT strain, and 13 and 14 
represent products of the HA-ΔPNT strain. Layout of these illustrations is as 
described in Figure 12B. 
C. Anti-MCD (green) and anti-HA (red) immunoblot of concentrated supernatants. 
Numbers above protein bands correspond to illustrations on the right side of the 
figure. Illustrations 1 and 2 represent products of the HAPRR strain, 3 represents the 
product of the HA-ΔCS strain, and 4-6 represent products of the HA-ΔPNT strain. 
Layout of these illustrations is as described in Figure 12B. Deletion of the MCT 
prevents FHA release, while deletion of the PNT promotes release. Additionally, 
deletion of the PNT results in translocation of the prodomain into the extracellular 
space where it can be separated from FHA in an SphB1-dependent manner.  
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whole-cell lysate, but not in supernatants (Figure 15C; proteins in culture 
supernatants were resolved using an 8% polyacrylamide gel, allowing lower 
molecular weight proteins to be visualized at the expense of separating higher 
molecular weight proteins), also indicates that the C-terminus of the prodomain is 
present in an intracellular compartment in this strain as these polypeptides would 
have been released into the supernatant fraction if they had been located 
extracellularly. In whole-cell lysate of the HA-ΔMCT strain that also contains the 
ΔsphB1 deletion, more unprocessed FhaB protein was detected, as well as a 
polypeptide of about 230 kDa, which is presumably a product of cleavage by the 
unidentified protease(s) (Figure 15B, bands 11 and 12, respectively). No 
polypeptides of any size were detected by either antibody in supernatant fractions of 
the HA-ΔMCT strain, regardless of whether sphB1 was wild-type or deleted, 
indicating that the MCT is required for FHA release. The MCT, therefore, is required 
for release of FHA, but not for intracellular retention of the prodomain. 
 
In the HA-ΔPNT strain, FhaB was extensively processed, resulting in the 
formation of several polypeptides of around 250 kDa (Figure 15B, bands 13). The 
processing was SphB1-dependent as only full-length FhaB, which was recognized 
by both the anti-MCD and anti-HA anti-bodies, was present in whole-cell lysate of 
the HA-ΔPNT strain that also contained the ΔsphB1 deletion (Figure 15B, band 14). 
The HA-ΔPNT strain released a large amount of ~250 kDa polypeptides that were 
recognized by only the anti-MCD antibody and lower molecular weight (~50-100 
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kDa) polypeptides that were recognized only by the anti-HA antibody, into the culture 
supernatant (Figure 15C, bands 4 and 5, respectively). The HA-ΔPNT strain with the 
ΔsphB1 deletion released a large amount of full-length protein that was recognized 
by both antibodies (Figure 15C, band 6). These results indicate that sequences 
within the PNT are required for retention of the C-terminus of the prodomain in an 
intracellular compartment and are not required for release of FhaB/FHA from the cell 
surface. In fact, the HA-ΔPNT strain releases more FhaB/FHA from the surface than 
the wild-type strain, suggesting that the PNT influences FHA release in a negative 
manner. 
 
To further investigate the location of the prodomain in the HA-ΔMCT and HA-
ΔPNT strains, we performed dot blots (Figure 16). In the HA-ΔMCT strain (sphB1WT), 
only the MCD, and not the HA epitope, was detected on the surface of whole cells 
(Figure 16B; note that as with Figure 13B, the schematics below the dot blots 
indicate only the various polypeptide species, not their relative abundances). Lysing 
these cells resulted in detection of the HA tag, indicative of an intracellular 
prodomain C-terminus. Whole cells of the HA-ΔMCT,ΔsphB1 strain were detected at 
a low level by the anti-HA antibody, suggesting that some prodomain C-terminus 
was surface-localized. This result suggests that lack of the MCT can overcome, to 
some extent, the ability of the PNT to block translocation of the prodomain through 
FhaC to the cell surface. If so, then in the HA-ΔMCT strain that is wild-type for 
sphB1, the small amount of prodomain that is translocated to the surface would be 
cleaved in an SphB1-dependent manner and released into the supernatant. Indeed,  
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Figure 16 
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Figure 16 
 
The prodomain of the HA-ΔMCT strain is mostly intracellularly localized while that of 
the HA-ΔPNT strain is extracellularly localized 
 
A. Schematic of proteins used in dot blot experiments. Mutations were also made in 
a ΔsphB1 background. 
B. At the top, anti-MCD (green) and anti-HA (red) immuno-dot-blot of HAPRR, HA-
ΔMCT and HA-ΔPNT strains. Normalized amounts of whole cells and boiled lysates 
were applied. Below, illustrations of immuno-stained samples. Layout of these 
illustrations is as described in Figure 13B.  
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a closer analysis of concentrated supernatants revealed that the HA-ΔMCT strain 
released cleaved prodomain polypeptides, albeit much less efficiently than the HA-
ΔCS and HA-ΔPNT strains (Figure 17B). Boiling the HA-ΔMCT,ΔsphB1 strain 
increased detection by the anti-HA antibody, indicating that although some 
prodomain crossed the outer membrane, most of it was retained intracellularly.  
 
In the HA-ΔPNT strain (sphB1WT), no HA epitopes were detected on the 
surface of whole-cells (Figure 16B), consistent with the previous observation of 
extensive SphB1-dependent cleavage of surface-localized prodomain (which was 
also observed in the HA-ΔCS strain). Boiling these cells resulted in weak detection 
of the HA tag, which, as with the HA-ΔCS strain, likely represents FhaB prior to 
translocation across the outer membrane. In the HA-ΔPNT,ΔsphB1 strain, both the 
anti-MCD and the anti-HA antibodies were able to detect surface protein, consistent 
with the prodomain crossing the outer membrane but not being cleaved in the 
absence of SphB1. Collectively, these data implicate the PNT as the subdomain 
responsible for intracellular localization of the prodomain C-terminus. 
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Figure 17 
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A small amount of prodomain is released from B. bronchiseptica with a deletion of 
the MCT
A. Schematic of FhaB proteins used in experiment. Domain layout is the same as 
that of Figure 14A. Mutations were also made in a ΔsphB1 background.
B. Anti-MCD (green) and anti-HA (red) immunoblot of concentrated supernatants. On 
the left is a merge showing release of prodomain from HA-ΔCS, HA-ΔMCT, and 
HA-ΔPNT strain. On the right is an image of the same immunoblot, with the 700 nm 
(red) channel isolated and enhanced to facilitate the visualization of prodomain 
bands released into the supernatant of the ΔMCT strain.
Chapter IV – Identification of C-terminal determinants of FHA release 
 
The MCD appears to contain determinants of FHA release 
 
One of the unexpected results of deletion of the MCT was the prevention of 
FHA release from the surface of B. bronchiseptica (Figure 15C). This result 
prompted us to examine the extent of MCD-dependent FHA release. ΔMCD-PD 
(which contains a deletion of the region encoding the MCD and prodomain) and 
Δ28-PD (a strain that produces FhaB lacking the 28 aa absent from FhaS MCD and 
the entire prodomain) contain greater levels of protein corresponding to FHA in 
whole cell lysates than seen in RBX11 (Figure 18B). Concentrated supernatants 
showed that both ΔMCD-PD and Δ28-PD released much less FHA than RBX11. 
RBX20 (deleted for fhaB and fhaS) was used as a negative control for FHA 
detection. It is worth noting that while Δ28-PD released very little FHA, a strain 
producing a slightly larger FhaB protein (ΔPD) released wild-type levels of FHA 
(Chapter 5, Figure 20), suggesting that the 147 aa difference at these strains’ C-
termini could be a key determinant of release potential. 
 
To expand our analysis, we constructed a strain with an in-frame deletion of 
the entire MCD (HA-ΔMCD) and a strain with a deletion of the MCD N-terminus (HA-
ΔMNT). We also constructed a strain in which a stop codon was introduced before
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Figure 18 
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the MCT (ΔMCT-PD). While Western blot analysis of whole-cell lysate shows that 
these strains all contain cellular FhaB (Figure 19B), concentrated supernatants 
indicates that in all of these strains, mature FHA was poorly released from the cell 
surface (Figure 19C), reinforcing the idea that the MCD is an important determinant 
of FHA release competency. 
 
While the above results indicate that the MCD plays an important role in the 
release of FHA from the cell surface, they also indicate that the FhaB prodomain is 
not a release determinant. This is best exemplified by MCD mutants made in wild-
type and prodomain-deleted backgrounds. Comparison of i) ΔMCD-PD to HA-ΔMCD 
and ii) ΔMCT-PD to HA-ΔMCT demonstrated that the presence or absence of the 
prodomain alone does not affect FHA release. Though the results are preliminary, by 
identifying the FhaB MCD as a determinant of release competency, we further our 
understanding of the mechanism by which FHA is released from the cell surface. 
Previous reports arguing that the N-terminal 80 kDa of FhaB contain FHA-release 
information are only partially true, as it is now clear that sequences across the entire 
FHA protein may contribute to release competency. 
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A. Schematic of FhaB proteins used in experiment. Mutations were also made in a 
ΔsphB1 background.
B. Anti-CRD (green) and anti-HA (red) immunoblot of whole-cell lysates.
C. Anti-CRD (green) immunoblot of concentrated supernatants. On the membrane 
onto which concentrated supernatants were transferred, CyaA was stained nonspe-
cifically with anti-CRD antibody, resulting in false positives for FHA release.
Chapter V – Identification and characterization of additional subdomains of the FhaB 
prodomain 
 
The prodomain comprises several distinct subdomains 
 
Having demonstrated that the FhaB prodomain N-terminus (PNT) serves as 
an important subdomain for prodomain localization, we sought more specifically to 
identify subdomains that may have a role in FHA biogenesis and function. Residues 
3390-3612 (numbering relative to FhaB of B. bronchiseptica RB50) contain a high 
number of prolines (Figure 5). The sequence of this proline-rich region (PRR) is 
highly conserved across all FhaB proteins of the Bordetella genus, but has no 
similarity to other bacterial proteins. Predictions using PHYRE2, however, indicate 
that the PRR may share structural similarity to TonB (Kelley and Sternberg, 2009). 
TonB is a highly conserved protein involved in iron acquisition in Gram-negative 
bacteria. A proline-rich portion of the TonB protein spans the periplasm in order to 
interact with and transduce conformation-shifting signals to outer membrane 
transport proteins (Postle and Larsen, 2007). A (PK)5 motif of TonB has been 
implicated in outer membrane protein association in vitro (Brewer et al., 1990), 
though in vivo functions remain uncertain. In TonB, this (PK)5 motif appears to be 
important for dimerization of TonB proteins when proximal to outer membrane iron 
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transporters. A (PK)5 motif is also present within the PRRs of B. pertussis and B. 
parapertussis, while a (PA)6(PK)4 motif is present in the same position in FhaB of B. 
bronchiseptica. C-terminal to the PRR, the 98 aa at the extreme C-terminus (ECT) of 
the prodomain (Figure 5) are identical amongst the nine FhaB proteins of B. 
bronchiseptica, B. pertussis, and B. parapertussis strains for which genome 
information is available (sequences provided by the Wellcome Trust Sanger 
Institute). However, this region shows no similarity to other proteins. The central 
region of the prodomain, residues 2602-3389, also shares no significant similarity 
with other proteins. 
 
The extreme C-terminus of the prodomain is a negative regulator of SphB1-
independent FhaB processing and is required for virulence 
 
To investigate the roles of the prodomain subdomains C-terminal to the PNT 
in FHA maturation and secretion, we constructed strains with stop codons at various 
locations in fhaB and compared FhaB maturation and FHA secretion in these strains 
to that of wild-type B. bronchiseptica (Figure 20A). Whole-cell lysates of strains 
producing FhaB proteins that lack the ECT (ΔECT), the PRR and ECT (ΔPRR-ECT), 
or most of the prodomain (ΔPD), contained no detectable full-length FhaB protein 
and the amount of mature FHA appeared to be increased relative to the amount 
present in wild-type bacteria (Figure 20B). The ECT therefore appears to function as 
a negative regulator of FhaB maturation; in its absence, FhaB is ‘hyper-processed’ 
such that none of the preprocessed FhaB protein is detectable. The fact that the  
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Figure 20 
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The ECT of the prodomain suppresses SphB1-independent processing of FhaB
A. Schematic of FhaB proteins used to demonstrate ECT suppression of SphB1-
independent FhaB processing. Mutations were also made in a ΔsphB1 background.
B. Anti-MCD (green) immunoblot of strains used to demonstrate ECT-regulation of 
SphB1-independent of FhaB. In supernatant immunoblot, samples from wild-type 
sphB1 background are diluted 1:2 in 1X sample buffer.
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FhaB/FHA profiles in the ΔPRR-ECT and ΔPD strains were nearly identical to those 
of ΔECT strain suggests that either i) these regions of the prodomain do not 
contribute to FHA maturation in a manner that can be assessed using this assay, or  
ii) that deletion of the ECT is dominant to deletion of the other prodomain 
subdomains. The ECT-dependent hyper-processing of FhaB also occurred in 
ΔsphB1 strains, indicating that the inhibitory activity of the ECT is directed at the 
unidentified protease and not SphB1. These data also suggest that the rate-limiting 
step in FhaB processing is cleavage by the unidentified protease. 
 
The slightly different mobilities of FHA and FHA’ are apparent in the 
immunoblot of proteins recovered from culture supernatants that is shown in Figure 
20B. Slightly more FHA appeared to be released in ΔECT, ΔPRR-ECT and ΔPD, 
consistent with FhaB being hyper-processed in these strains, resulting in increased 
release of FHA. In ΔsphB1 strains lacking the ECT, two mature polypeptides were 
detected – FHA′ and a slightly smaller protein. The latter is the size of the FHA 
isoform, but cannot be FHA since generation of FHA is SphB1-dependent. This 
suggests that in addition to affecting the rate of FhaB processing, the ECT may also 
affect the sites at which SphB1-independent cleavage occurs. 
 
As mentioned in Chapter III (page 53), we originally constructed a strain 
producing FhaB with a hemagglutinin (HA) epitope seven residues N-terminal to the 
C-terminus of FhaB (CTHA) for prodomain localization studies (Figure 10). 
Immunoblot analysis indicated that FhaB was hyper-processed in this strain (Figure 
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10B), reminiscent of ECT truncations. These data suggest that the HA epitope of 
CTHA disrupted the function of the ECT and supports the conclusion that the ECT 
functions to inhibit FhaB processing. 
   
We next examined B. bronchiseptica with truncations of the ECT in vivo. Mice 
were infected with ~5x104 CFU of either RBX11 (our wild-type B. bronchiseptica 
strain) or ΔECT. Lung burdens of both strains were the same 24 hpi (Figure 21B). At 
day 11, however, ΔECT had been completely cleared from the lungs while RBX11 
persisted at a high level. Since the truncation in ΔECT was achieved by 
cointegration of a stop codon before the ECT, we wanted to be certain that the 
plasmid used for cointegration had not been lost from bacteria in the lungs. Plating 
of lung homogenates on LB-Gm plates revealed that no plasmid loss from 
cointegrates. Examination of histology showed RBX11-infected lungs with low to 
moderate inflammation at 24 hours and 11 days (Figure 22B). Interestingly, ΔECT 
induces an inflammatory response comparable to that of RBX11, despite complete 
clearance of bacteria 11 days post-infection. 
 
The C-terminus of the MCD is required for relief of inhibition of the unidentified 
protease by the ECT 
 
The presence of the ~150 kDa polypeptide recognized by both anti-MCD and 
anti-HA antibodies that was present in whole-cell lysate of the HA-ΔMCT strain 
(Figure 15B) suggests that the MCT may influence processing of FhaB by the  
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Figure 21 
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Truncation of the prodomain ECT causes a Bordetella persistence defect in vivo
A. Schematic of FhaB proteins in strains used to infect mice.
B. Bacterial burdens in mice. The right lungs of mice were harvested at the specified 
times, homogenized, and plated for burden counts. ΔECT homogenate was plated on 
BG-Sm and BG-SmGm plates to ensure that plasmid was not lost from the strain. 
Experiments were performed in duplicate.
Courtesy of Jeffrey Melvin and Kurtis Host
*** p < 0.005
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Figure 22 
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The ΔECT strain causes a wild-type inflammatory response
A. Schematic of FhaB proteins in strains used to infect mice.
B. Histology of mice lungs. The left lungs of mice were sectioned for histopathology 
analysis. Despite burden discrepancies between wild-type B. bronchiseptica and 
ΔECT burdens, there is no apparent difference in host inflammatory response.
Courtesy of Jeffrey Melvin and Kurtis Host
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unidentified protease. We hypothesized that lack of the MCT could i) act to render 
the unidentified protease inactive, ii) cause the cleavage site to be inaccessible to 
the protease, or iii) cause the protease to be constitutively inhibited by the ECT. To 
investigate these possibilities, we constructed a strain producing FhaB with both the  
HA-ΔMCT deletion and the ECT truncation (HA-ΔMCTΔECT). The ~150 kDa 
polypeptide that was recognized by both antibodies in whole-cell lysate of the HA-
ΔMCT strain was not detected in whole-cell lysate of the HA-ΔMCTΔECT strain in 
whole-cell lysate (Figure 23B), indicating that prodomain was being both cleaved 
from FhaB and efficiently degraded. Since this experiment implicates the ECT a 
determinant of prodomain degradation, we hypothesize that the unidentified 
protease (which appears to be regulated by the ECT) is more directly responsible for 
degradation. Consistent with previous data (Figure 15B), it appears that in the HA-
ΔMCT strain, the ECT inhibited the activity of the unidentified protease. In fact, given 
the stability of the ~150 prodomain fragment, the ECT appears to be constitutively 
inhibitory of SphB1-independent proteolysis in the HA-ΔMCT strain. Such results are 
consistent with the hypothesis that the MCT is involved in delivering a signal to the 
ECT that causes the ECT to stop inhibiting the unidentified protease. Such a signal 
could be the folding of the MCD (and therefore folding of the MCT) into a functional 
conformation or the association of the MCD with its receptor on host cells, which 
may result in folding of the unidentified protease cleavage site into an accessible 
conformation. 
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Figure 23 
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A. Schematic of FhaB proteins in strains used in experiment. Mutations in a ΔsphB1 
background are noted.
B. Anti-MCD (green) and anti-HA (red) immunoblot of whole cell lysates. Truncation 
of the ECT from FhaB of the ΔMCT strain restores degradation of the cleaved prodo-
main.
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The proline-rich region of the FhaB prodomain does not affect FHA biogenesis but is 
required for virulence 
 
While the hyper-processing phenotype of the ΔECT and ΔPRR-ECT strains 
implicated the ECT in FhaB stability and maturation dynamics, they did not reveal a  
role for the PRR. We, therefore, created a strain (ΔPRR) with an in-frame deletion of 
the prodomain’s PRR in order to examine its role on the maturation of FHA. Whole-
cell lysate analysis revealed that the PRR deletion strain produced similar levels of 
full-length FhaB and processed FHA as wild-type B. bronchiseptica, and that the 
FHA isoforms generated were of the same size as those made in our wild-type strain 
(Figure 24B). Release of FHA into the supernatant was also unaltered (Figure 24C). 
We also constructed a strain (ΔPK) in which the (PA)6(PK)4 motif of the PRR was 
deleted.  Given the lack of biogenesis phenotype in the ΔPRR strain, it came as little 
surprise that the (PA)6(PK)4 deletion had no affect on the maturation profile of FHA 
(Figure 24B or 24C). 
 
Since our in vitro experiments did not reveal a phenotype for the PRR, we 
examined the ΔPRR strain in vivo. Mice were infected with RBX11 (B. 
bronchiseptica deleted for fhaS to simply cloning) or ΔMCD-PD (a strain in which the 
region of fhaB encoding the MCD and prodomain has been deleted) as controls for 
typical and hyper-inflammatory host responses, respectively. RBX11 burdens 
peaked 3 days post-infection, but the strain persisted through day 11 (Figure 25). 
Over the course of infection, mice infected with ΔMCD-PD exhibited a ‘bi-modal’  
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Figure 24 
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A. Schematics of FhaB proteins in strains used in experiment. Mutations in a 
ΔsphB1 background are noted.
B. Anti-MCD (green) and anti-HA (red) immunoblot of whole-cell lysates. Deletions in 
the ΔPRR and ΔPK strains did not affect FhaB biogenesis.
C. Anti-MCD (green) immunoblot of concentrated supernatants. Deletions in the 
ΔPRR and ΔPK strains did not affect release of mature FHA.
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Figure 25 
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Deletion of the prodomain PRR causes a Bordetella persistence defect in vivo
A. Schematic of FhaB proteins in strains used to infect mice.
B. Bacterial burdens in mice. The right lungs of mice were harvested at the specified 
times, homogenized, and plated for burden counts. ΔMCD-PD was included as a 
control for persistence in response to the host bi-modal response. Experiments were 
performed twice.
* p < 0.5
*** p < 0.005
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response – a hyper-inflammatory response that will either clear bacteria or 
undermine the host’s own defenses. By day 3, the consequence of such a response 
was efficient clearance of bacteria or dramatic proliferation of bacteria in immune-
compromised hosts (Inatsuka et al., 2005; Henderson et al., 2012). The ΔPRR strain 
appeared defective for the initial colonization of mice at day 3. Burdens continued to 
decrease compared to RBX11, with bacteria cleared 11 days post-infection. 
Preliminary results suggest that deletion of the (PA)6(PK)4 motif had no affect on the 
ability of B. bronchiseptica to establish and maintain infection (Figure 26). 
 
Histology revealed a host response to the ΔPRR strain dramatically different 
to that of RBX11 or ΔECT. While RBX11 caused low-to-moderate inflammation over 
the course of infection (day 11 lungs of RBX11-infected mice may serve as a 
reference for an uninflammed lung), ΔPRR caused a dramatic inflammatory 
response 1 and 3 days post-infection, as indicated by an influx of neutrophils and 
macrophages into the alveolar space (Figure 27B). By day 11, however, lung 
inflammation of mice infected with the ΔPRR strain was about as low as that of mice 
infected with RBX11. Despite the high degree of inflammation at days 1 and 3, mice 
infected by the ΔPRR strain were never moribund. Even ΔMCD-PD, noted in the 
past for its induction of a hyper-inflammatory response (Henderson et al., 2012), 
paled in comparison to ΔPRR in its ability to cause inflammation in mouse lungs. It is 
likely that the nature of hyper-inflammatory response caused by ΔPRR is different 
than that of ΔMCD-PD since no bi-modal response was observed in mice infected 
with ΔPRR despite greater inflammation in their lungs. 
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Figure 26 
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A. Schematic of FhaB proteins in strains used to infect mice.
B. Bacterial burdens in mice. The right lungs of mice were harvested at the specified 
times, homogenized, and plated for burden counts. Since the ΔPK strain was made 
in an HAPRR background, RBX11 was included as a control against which HAPPR 
and ΔPK were compared. Experiments were performed once.
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Figure 27 
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The ΔPRR strain causes an extreme hyper-inflammatory response
A. Schematic of FhaB proteins in strains used to infect mice.
B. Histology of mice lungs. The left lungs of mice were sectioned for histopathology 
analysis. Compared to the inflammatory response of wild-type B. bronchiseptica and 
ΔMCD-PD (which is characterized as being hyper-inflammatory), ΔPRR induces an 
extreme inflammatory response 24 and 72 hours post-infection, but returns to near-
wild-type histopathology by day 11. 
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Plasmid-borne prodomain expression offer insights as to prodomain fate 
 
As an alternative method to understanding the function of the prodomain, we 
examined whether the prodomain could function in trans to the N-terminal ~250 kDa 
of FhaB (corresponding to mature FHA). The approach was to design plasmid 
constructs in the broad-range vector pBBR1-MCS (medium copy in B. 
bronchiseptica). Sequences encoding the fhaB promoter and FhaB prodomain were 
cloned into the vector. The prodomain-encoding DNA was designed with and without 
sequences encoding (i) an FhaB signal peptide and (ii) a PRR/ECT, totaling four 
constructs (Figure 28A). Plasmids were introduced to B. bronchiseptica strains with 
varying fhaB mutations (Figure 28A), including RBX11 (wild-type FhaB), ΔPD 
(prodomain-truncated to test for trans complementation), PDComp (Δ28-PD with the 
prodomain complemented in cis), ΔMCD-PD (deleted of the MCD and prodomain), 
and RBX20 (ΔfhaB, a negative control for FhaB). 
 
Western blots were performed whole-cell lysate of all the strain/plasmid 
combinations (Figures 28B). Staining against the N-terminus of the prodomain 
revealed that ~140 kDa prodomain could only be detected when the plasmid 
construct included the PRR and ECT of the prodomain (Figures 28B). It cannot be 
ruled out, however, that smaller peptide species existed that were not reactive to our 
antibody. This result parallels our previous result showing that the ECT is required 
for stability of the prodomain in the context of full-length FhaB, though the plasmid- 
based approach does not discern between the PRR or the ECT being responsible 
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for stability of the over-expressed prodomain. Furthermore, plasmid constructs were 
only introduced to sphB1WT backgrounds, so we cannot conclude anything with 
regards to the proteases that are responsible for prodomain degradation in bacteria 
containing the PRR/ECT-deficient prodomain constructs. 
 
The second result of the plasmid-based approach was that trans-conjugates 
suffered from toxicity when grown under BvgAS plus-phase modulating, with 
colonies growing very poorly compared to bacteria with no plasmid (Figures 29B and 
29C). This toxicity was alleviated when strains were grown on plates containing 20 
mM MgSO4 (which modulates Bordetella to BvgAS minus-phase), indicating that 
toxicity was dependent on the expression of the plasmid-borne prodomain. Each of 
the four plasmid constructs caused toxicity to recipient bacteria, which is surprising 
given the apparent instability of prodomain polypeptides synthesized without a 
PRR/ECT – a result that suggests that even a transiently stable prodomain may be 
toxic. Of further curiosity was the fact that toxicity was less pronounced in trans-
conjugates of the RBX20 (ΔfhaB) background (Figure 29C), suggesting that toxicity 
was partly dependent on FhaB. Indeed, based on toxicity to ΔMCD-PD trans-
conjugates, it appears that the β-helix is the FhaB-dependent toxicity factor in our 
plasmid-based approach.
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Figure 28 
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Figure 28, continued 
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A. Schematic of proteins, loci, and plasmids used in experiment. At the top are 
schematics of the proteins that were used and a schematic illustrating the disruption 
of fhaC in the RBX11::pSJ22 strain. At the bottom are plasmid constructs used in 
experiment containing variants of the FhaB prodomain.
B. Anti-MCD (green) and anti-PD (red) immunoblot of whole-cell lysates. Prodomain 
expressed from medium copy plasmids was only immuno-detected in trans-
conjugates contained plasmid constructs that included the PRR-ECT.
C. Anti-PD (green) immunoblot of whole-cell lysates. Prodomain expressed from 
medium copy plasmids was only immuno-detected in trans-conjugates contained 
plasmid constructs that included the PRR-ECT.
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 Figure 29 
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Figure 29, continued 
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Figure 29 
 
Over-expression of the prodomain alone causes toxicity to B. bronchiseptica in a 
manner co-dependent on the presence of the FhaB β-helical region 
 
A. Schematic of proteins, loci, and plasmids used in experiment. At the top are 
schematics of the proteins that were used and a schematic illustrating the disruption 
of fhaC in the RBX11::pSJ22. At the bottom are plasmid constructs used in 
experiment containing variants of the FhaB prodomain. 
B. Legend and healthy recipient B. bronchiseptica. On the left, a legend for recipient 
strains on the plates in Figure 29C. On the right, recipient strains with no prodomain 
plasmid construct develop healthy colonies on BG plates containing no MgSO4. 
C. Trans-conjugates containing prodomain plasmid constructs are unable to grow on 
Bvg plus-phase modulating plates, though trans-conjugated RBX20 grows 
moderately well. All trans-conjugates grow well on Bvg minus-phase modulating 
plates. Strains ΔMCD-PD, ΔPD and PDComp were not trans-conjugated with pSP-PD-
PRR. 
 
 
Chapter VI – Discussion and future directions 
 
Summary and Concluding Thoughts 
 
The experiments described in this work yielded four primary findings: (i) the 
FhaB prodomain remains in an intracellular compartment during FHA biogenesis, (ii) 
the prodomain affects the conformation of the FHA MCD, (iii) the PRR and ECT of 
the prodomain are important for FHA-mediated virulence, and (iv) the MCD of FhaB 
is determinant of FHA release potential. Based on these results, we propose a 
revised model for secretion by the FhaB-subfamily of TPS systems. The revisions 
relate primarily to events occurring after the β-helical shaft has been exported to the 
cell surface (Figure 30). The model states that as the MCT is secreted, FhaC 
changes from a release-incompetent state to a release-competent state (the shift in 
FhaC release competency is indicated in Figure 30 by a change in FhaC color from 
red to green). Subsequent FhaB transit through FhaC is halted by the PNT, which 
we postulate folds into a conformation that is incompatible with translocation. 
According to this model, the prodomain functions as a tether that constrains the 
conformations that the extracellularly located MCD may sample while folding into a 
functional structure. Alternatively, the prodomain may control the rate of 
translocation of the MCD, with rate-limited translocation being required for the MCD 
to fold properly. We hypothesize that upon achieving a functional conformation, the
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MCD signals maturation-cleavage readiness, resulting in FhaB cleavage by the 
unidentified protease(s). The prodomain is rapidly degraded and additional SphB1-
dependent processing occurs. Fully matured FHA is then released into the 
extracellular environment by an, as yet, unknown mechanism.  
 
We reported previously that the prodomain is required for FHA function in vivo 
and we also provided evidence that the MCD is an important functional domain, if 
not the functional domain, of FHA during infection (Mazar and Cotter, 2006; Julio et 
al., 2009). In this study we used semi-native PAGE, proteinase-K digestion and 
cysteine residue accessibility experiments to determine that the FhaB prodomain 
affects the conformation of the MCD. These results indicate that the prodomain 
functions as an intramolecular chaperone that controls the folding of the MCD. 
Proteinase-K digestion and dot blot experiments demonstrated that the prodomain 
remains intracellular while the MCD is extracellular, but they did not reveal whether 
the C-terminus of the prodomain remains in the cytoplasm or the periplasm. 
Regardless of its exact intracellular location, the FhaB intramolecular chaperone 
domain (the prodomain) and the functional domain it controls (the MCD) are 
separated by at least one membrane. Although intramolecular chaperones that 
affect the conformation of functional domains have been described, they typically 
colocalize with their functional domains, acting as molecular scaffolds that guide the 
folding of the active domain of the mature protein via direct protein-protein 
interactions. The best-characterized example of this family of intramolecular 
chaperones is subtilisin E of B. subtilis (Shinde and Thomas, 2011). The FhaB 
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prodomain appears to function in an entirely different manner since it does not 
colocalize with the conformationally mature MCD. The simplest model is that the 
prodomain, via its intracellular location, functions as a tether that constrains the 
folding space of the MCD such that its functional conformation is the preferred fold 
among those available for sampling. Although a more complex scenario, it is also 
possible that the FhaB prodomain, either directly or indirectly from inside the cell, 
influences the translocation rate of the MCD such that the MCD is translocated 
across the outer membrane in a manner compatible with its proper folding on the cell 
surface. To our knowledge, neither of these mechanisms for the control of protein 
folding has been described previously. However, a similar concept has been 
described in the case of the E. coli autotransporter EspP. In this case, it is 
hypothesized that, prior to cleavage by leader peptidase, a cytoplasmically located 
extended signal peptide alters the conformation of the periplasmically located β-
domain and, consequently, its ability to integrate into the outer membrane (Szabady 
et al., 2005).  
 
Our experiments identified the PNT as the subdomain responsible for 
intracellular retention of the prodomain. One mechanism by which the PNT may 
mediate intracellular prodomain retention is by folding into a conformation 
incompatible with translocation through FhaC (Figure 30). Alternatively, the PNT 
may interact with another molecule or molecular complex that prevents export 
through FhaC. Whatever the mechanism, because this subdomain is conserved 
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among TpsA proteins of the FHA subfamily, intracellular retention of C-terminal 
prodomains and the mechanism by which PNTs function may also be conserved.  
 
As suggested by our model, we do not believe that the only role for the 
prodomain is to function as a tether (if the tether hypothesis is even correct). We 
showed previously that a B. bronchiseptica strain that produces an FhaB protein 
lacking only the C-terminal 339 aa (and hence containing an intact PNT) is defective 
for tracheal colonization in rats (Mazar and Cotter, 2006). These data provide 
evidence that sequences C-terminal to the PNT are required for prodomain function. 
We and others have also noted the presence of a proline-rich region near the C-
terminus of the prodomain, but the role of this region is currently unknown. In this 
work, we examined the role of the proline-rich region (PRR) as well as the extreme 
C-terminus (ECT) subdomains. Given the unusual amino acid composition of the 
PRR, we were surprised to see no in vitro phenotype for the strain in terms of FHA 
biogenesis. Only when tested in mice did it become clear that the PRR has a 
dramatic role in virulence – histology showed that at a relatively low dose (~5x104 
CFU), the ΔPRR strain induced a very strong inflammatory response in the lungs 
(remarkably, without affecting the outward health of infected mice), and bacteria 
were efficiently cleared from the lungs. Immediately C-terminal to the PRR is the 
ECT, and though the two subdomains are adjacent, they have rather different 
phenotypes. While the ΔPRR strain had no apparent FHA biogenesis phenotype, the 
ΔECT strain appeared to hyper-process full-length FhaB into mature FHA. 
Introduction of an HA epitope into the ECT, although unintended, also resulted in the 
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hyper-processing biogenesis. While the ΔPRR strain caused a severe inflammatory 
response in the lungs of mice, the ΔECT strain (though only examined at days 1 and 
11 post-infection) appear to have elicited an inflammatory response matching that of 
wild-type B. bronchiseptica. The main commonality shared by the ΔPRR and ΔECT 
strains is that they are both fully cleared from the lungs of mice 11 days post-
infection, indicating that both of these C-terminal subdomains are important for 
persistence. 
 
As described, early experiments on prodomain function and fate yielded 
perplexing results. New insights and fresh eyes, fortunately, allow us to make some 
sense of our plasmid-based approach to prodomain studies. The experimental 
design was such that prodomain was over-expressed as a standalone unit. Under 
normal circumstances, Bordetella expresses, cleaves and degrades the prodomain 
at single copy – potentially in order to prevent prodomain-dependent toxicity. In 
contrast, our trans-conjugates may have synthesized plasmid-encoded prodomain to 
an extent that B. bronchiseptica was unable to degrade prodomain quickly enough to 
avoid toxicity. This hypothesis, however, does not reconcile with the fact that trans-
conjugates expressing prodomain without the PRR/ECT also suffered from toxicity, 
despite the absence of prodomain detection on Western blots. Along a different line, 
our current understanding of intracellular prodomain localization gives us new 
perspective on the nature of the signal peptide included in some of our plasmid 
constructs. Two of the four plasmids contain no signal peptide, yet the cellular 
toxicity and prodomain Western blot profiles of trans-conjugates expressing signal 
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peptide-less prodomain are the same as those of trans-conjugates expressing 
signal-peptide-containing prodomain. Although these phenotypes may very well be 
artifacts of the over-expression system, they indicate that the signal peptide-
mediated transit across Sec is not necessary for medium-copy prodomain function. 
Although preliminary, such data suggest that the prodomain may, in fact, function in 
the cytoplasm of Bordetella under wild-type circumstances. 
 
Though it is too early to incorporate the PRR and ECT into our model of 
biogenesis and virulence, it is safe to say that subdomains C-terminal to the PNT 
(potentially including the PRR and ECT) play a role in FHA maturation. We 
hypothesize that proper folding of the MCD on the cell surface is somehow sensed 
by the prodomain to trigger continued FHA maturation (i.e. to stimulate cleavage and 
degradation of the prodomain and then release of mature FHA). This would occur 
regardless of whether the prodomain functions as a tether or a translocation rate 
limiter and we hypothesize that regions of the prodomain C-terminal to the PNT are 
important for these steps in FHA biogenesis. If the prodomain functions as a limiter 
of MCD translocation rate, then subdomains C-terminal to the PNT may also be 
involved in somehow controlling the rate of translocation through FhaC, possibly by 
transiently influencing the conformation of the MCD in the periplasm. Our future 
studies will be aimed at testing these hypotheses.  
 
Our data on ECT-dependent maturation highlighted not only a potential 
intramolecular maturation regulator, but also in importance of SphB1-independent 
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proteolysis during FHA maturation. Although SphB1-independent proteolysis of 
FhaB to yield FHA* and FHA′ was apparent in previous studies (Coutte et al., 2001; 
Mazar and Cotter, 2006), this cleavage was considered ‘aberrant’ and occurring 
primarily in the absence of SphB1 (Coutte et al., 2001). In this work, we observed 
two circumstances in which prodomain polypeptides were generated that were not 
cleaved by the unidentified protease. In each case, the prodomain polypeptides 
were stable. The first instance was after proteinase-K digestion of the HAPRR strain 
(sphB1WT and ΔsphB1). The second was in the ΔMCT strain, in which FhaB 
underwent SphB1-dependent cleavage, but not SphB1-independent proteolysis. The 
fact that stable prodomain polypeptides were present in both of these cases, despite 
the fact that they were localized intracellularly and hence presumably accessible to 
the unidentified protease(s), suggests that the unidentified protease(s) is responsible 
for degradation of the prodomain and that it does so only in response to the normal 
sequence of events that occurs during FhaB translocation and maturation. We 
speculate, therefore, that cleavage/degradation by the unidentified protease(s) is an 
important regulated event during FHA biogenesis, and having identified the ECT as 
a potential regulator of the protease(s), we hope to be able to identify it/them and 
determine its/their spectrum of activity. 
 
While our results suggest a role for the unidentified protease(s), they fail to 
reveal an important role for SphB1 with regard to FHA biogenesis. SphB1-
dependent cleavage of FhaB occurs at multiple locations and with varying 
efficiencies in wild-type B. bronchiseptica and B. pertussis. Target promiscuity is 
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especially evident in the HA-ΔCS strain, in which, despite a sizeable deletion 
surrounding the PLFETRIKFID region, SphB1-dependent cleavage of FhaB 
occurred at alternate sites. Furthermore, the FhaB prodomains in the HA-ΔCS and 
HA-ΔPNT strains reached the extracellular space, where they were cleaved in an 
SphB1-dependent manner, suggesting that SphB1-dependent cleavage occurs 
regardless of prodomain location. Although ΔsphB1 mutants of B. pertussis and B. 
bronchiseptica are severely defective in mouse models of infection (Coutte et al., 2003) 
and our unpublished data), this virulence defect cannot be attributed solely to altered 
processing of FhaB because SphB1-dependent cleavage of other Bordetella 
proteins occurs (our unpublished data). It is also possible that SphB1 interacts with 
host cells in a manner independent of its affects on other bacterial proteins. 
Understanding the roles SphB1 plays in Bordetella biology, therefore, remains a 
challenging and currently unattained goal.  
 
When grown in broth, B. pertussis and B. bronchiseptica release a substantial 
amount of FHA into the culture medium. As FHA contributes to adherence of the 
bacteria to eukaryotic cells in vitro more than any other Bordetella virulence factor 
(Relman et al., 1990; Cotter et al., 1998; Mattoo et al., 2000), the fact that FHA is so 
efficiently released from the cell surface has been perplexing. Recent data have 
indicated that FHA also functions to modulate the inflammatory response (Inatsuka 
et al., 2005; Julio et al., 2009; Henderson et al., 2012). Although in vitro studies 
suggest that the released form of FHA can affect host cell signaling (McGuirk and 
Mills, 2000; Abramson et al., 2008; Dieterich and Relman, 2011), whether the 
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released form of FHA plays an important role during infection is unknown. The major 
obstacle to addressing this question is our current inability to construct a strain that 
is defective only for FHA release. Previous studies with B. pertussis showed that 
although short FHA molecules corresponding to the N-terminal ~30 and ~80 kDa of 
the protein (the TPS domain and part of the β-helical shaft) were efficiently released 
into culture supernatants, longer molecules that included most of the β-helical shaft 
or all of the β-helical shaft plus the N-terminal half of the MCD were poorly released 
(Renauld-Mongenie et al., 1996). If the initially synthesized FhaB polypeptide 
contained most of the prodomain, however, mature FHA was efficiently released 
(Renauld-Mongenie et al., 1996). These data suggest that sequences within the C-
terminal half of the β-helical shaft render the system incompetent for release and 
that sequences C-terminal to that region restore release competency. Our 
experiments now reveal a critical role for the MCD in allowing FHA release, 
suggesting that sequences within this region somehow cause the FhaB/FhaC 
complex to switch from a release-incompetent to release-competent state. How this 
switch might occur mechanistically is completely unknown, but the current body of 
knowledge allows us to propose a new model for molecular determinants of FHA 
release potential. Experiments done by us and others reaffirm at FHA44 (the TPS 
domain and ~75% of the R1 β-helical region) are efficiently released in both E. coli 
and B. bronchiseptica (Renauld-Mongenie et al., 1996) and our unpublished data). FHA 
release defects exhibited by strains such as ΔMCD-PD, ΔMCT-PD and Δ28-PD 
indicate that sequences in the C-terminal portion of the β-helix reduce the efficiency 
of FHA release (perhaps by reducing the rate of FhaB secretion). It is worth noting 
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that the predicted structures of the R1 and R2 β-helices are different (Kajava et al., 
2001), and differential folding propensities between the two regions might affect the 
dynamics of FhaB secretion. Alternatively, ‘covert’ β-helical regions exist in the β-
helical shaft that have non-repetitive sequence (Kajava et al., 2001), and it may be 
that these regions contains molecular directions that regulate secretion dynamics. 
The work presented here identifies sequences in MCD and PNT as additional 
determinants of FHA release efficiency, with the MCD promoting release and the 
PNT inhibiting it. Thus it appears that within the FhaB proprotein are quality control 
‘checkpoints’ that that systematically ensure that the protein is folding into a proper 
conformation while being secreted (Figure 31). We hypothesize that only upon 
achieving a functional conformation does FhaB signal its own maturation/release 
readiness. 
 
Although our results have provided insight into the mechanism of FHA 
secretion and maturation, they also raise the question of why FHA maturation and 
release is so complex, and they remind us that data obtained by studying bacteria in 
culture in the laboratory must be interpreted with caution. During infection, Bordetella 
spp. produce FHA while residing on the mucosal surface of the respiratory tract. We 
and others have assumed that the ‘mature’ ~250 kDa FHA protein is the functional 
form during infection. However, it is possible that precleaved FhaB (currently 
considered a secretion intermediate) performs an important biological role. Our data 
suggest that the prodomain confers tension across the outer membrane, restraining 
mobility of the MCD, and we propose that once the MCD has folded, conformational  
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Figure 31 
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PNT
339019803241 72
SP TPSD β-helix MCDRBX11
3710
Prodomain PRR
ΔMCD-PD
ΔMCT-PD
ΔPD
Δ28-PD
HA
ΔHA-∆PNT
FHA44
FHA Release
Yes
No
High
High
Yes
No
No
Contains release-inhibition sequences
Contains release-promotion sequences
The ‘checkpoint’ model of FhaB secretion efficiency and FHA release rate
Wild-type and mutant FhaB proteins are listed, as are their respective release 
profiles. Based on release patterns, we propose that the FhaB proprotein contains a 
hierarchical system of molecular determinants of secretion efficiency, with release-
inhibition sequences (circled red) suppressing secretion rate and release-promotion 
sequences (circled green) increasing secretion rate. Absence of inhibition 
sequences results in increased FHA release. Absence of promotion sequences 
results in decreased FHA release. We hypothesize that by affecting the rate of 
secretion, these sequences influence the rate at which FHA can achieve a functional 
conformation, and therefore the rate at which FHA can achieve a release-competent 
state.
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information may also be sent back across the membrane to trigger cleavage and 
degradation of the prodomain by the unidentified protease(s). The potential for the 
MCD to communicate signals across the outer membrane to the prodomain raises 
the intriguing possibility that those signals could be generated in response to events 
that occur during infection, such as binding to specific host cell receptors. Moreover,  
the possibility exists that those signals could affect processes in the bacterial cell in 
addition to those related to FHA maturation, such as, perhaps, signal transduction 
and gene expression changes.  
 
The PRR is a particularly attractive candidate for such signaling functions. 
Thus far, our in vitro experiments suggest that the PRR is not an FHA biogenesis 
factor, yet deletion of the PRR from B. bronchiseptica has a dramatic phenotype in 
vivo. Since, to the best of our knowledge, the prodomain is degraded after cleavage 
from FhaB, it stands to reason that the PRR performs its in vivo function exclusively 
in the context of full-length FhaB. Proteins containing regions of high proline 
concentration are not uncommon. The functions of these proteins and the 
functional/mechanistic contribution of their respective PRRs vary widely, however 
(Williamson, 1994). Our attention has especially been drawn to TonB, a protein 
ubiquitous to Gram-negative bacteria that is involved in acquisition of iron from the 
extracellular environment. TonB spans the periplasm via a central proline-rich region 
(Hannavy et al., 1990; Postle and Larsen, 2007). Doing so allows TonB to conduct 
energy generated in the cytoplasmic membrane by the electrochemical gradient to 
the outer membrane. It is thought that the ‘charging’ of TonB at the inner membrane 
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stores potential energy that is used to induce conformational changes of TonB’s 
outer membrane binding partners, siderophore transporters, such that iron can be 
translocated from the extracellular space to the periplasm. The proline-rich region of 
TonB is believed to provide trans-periplasmic structure to TonB, and is part of the C-
terminal portion of TonB that binds siderophore transporters. TonB also contains a 
(PK)5 motif, like that found in the PRR of B. pertussis and B. parapertussis FhaB, 
although this motif has not been characterized to have a standalone function.  
 
Future Directions 
 
The body of work discussed in this dissertation reveals that the prodomain is 
a complex polypeptide composed of numerous subdomains have distinct roles in 
FHA biogenesis and Bordetella infection. Having demonstrated that the PNT is 
required to keep the remainder of the prodomain intracellular, our attention now 
shifts to understanding the function of the intracellular PRR and ECT. The PRR is of 
particular interest since we observe such a dramatic PRR-dependent phenotype in 
vivo in terms of bacterial burden and lung inflammation, despite no readily apparent 
affect on FHA biogenesis in vitro. It is worth noting that the following experiments, 
while focused on characterizing the PRR, would be equally relevant to studies of the 
PNT, ECT and any subdomains that are later identified. 
 
The foremost priority for PRR studies is better characterize the host response 
to PRR-deficient Bordetella. In addit
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bacterial burdens, studies of bacterial dissemination, host cytokine production, 
immune cell recruitment, and host weight loss will provide valuable insight as to how 
the PRR of FhaB affects host interactions with Bordetella. These in vivo experiments 
would be nicely complemented by in vitro studies assessing the role of the 
Bordetella PRR in adherence to host cells, cytokine response to infection, and 
internalization by phagocytes. 
 
Understanding molecular and mechanistic bases for PRR-dependent 
phenotypes will be necessary to explain any host-side phenotypes that we observe. 
It is of particular interest to determine if the PRR, specifically, affects the 
conformation of the MCD, as we previously demonstrated the dependency of MCD 
conformation on the presence of the entire prodomain. While we are now able to 
claim that the prodomain (and therefore the PRR) remain intracellular during FHA 
biogenesis, we have not identified the subcellular compartment in which it resides. 
We hope that selective permeabilization studies will distinguish between cytoplasmic 
and periplasmic localization of the PRR, thereby offering insight as to its precise 
mechanism of virulence. Furthermore, since PRRs are often involved in protein-
protein interactions, it would be revealing to perform co-immunoprecipitation 
experiments to identify any binding partners for the PRR. PRRs have also been 
implicated as DNA binding domains, serving as transcription regulators (Williamson, 
1994). Although perhaps a stretch, the intracellular PRR may influence intracellular 
signaling events in response to host ieractions, ultimately regulating the expression 
of Bordetella virulence genes. Incubation of cell lines with wild-type and ΔPRR B. 
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bronchiseptica, followed by RT-qPCR of bacterial RNA would reveal any PRR-
dependent changes in virulence regulation. 
 
The work presented in Chapter IV highlights TpsA release as one of the 
current frontiers in TPS pathway research. The ‘checkpoint’ model of FHA secretion 
and release discussed above provides a starting point for systematic analysis of 
FhaB, with the goal of identifying and characterizing sequences that promote or 
hinder trafficking of FhaB to the extracellular space. Additionally, studies on FhaC 
may provide valuable insight into FHA release mechanics. Though preliminarily 
characterized in E. coli (Clantin et al., 2007), examinations of H1 and L6 of FhaC in 
Bordetella are warranted. Furthermore, structural predictions of B. bronchiseptica 
FhaC suggest that extracellular loop 5 is comparably long and flexible to L6, and 
thus studies of loop 5 might offer insights as to FhaC secretion and release 
mechanics. Finally, efforts are underway to engineer FhaB such that it cannot be 
released. One approach to accomplishing this goal is the addition of structural motifs 
to the N-terminus of the FhaB proprotein that preclude its transit through FhaC. 
Alternatively, we aim to create a fusion between the C-terminus of FhaC and the 
TPS domain of FhaB such that the N-terminus of mature FHA is linked to FhaC by a 
peptide bond. Should we be successful in constructing a strain of Bordetella that 
secretes but does not release functional FHA, we will have an invaluable tool for 
determining the function of FHA in vivo. 
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Appendix A – Experimental Methods 
 
Bioinformatics 
 
Proteins containing regions of similarity to the FhaB PNT were identified with a PSI-
BLAST search. ClustalW alignment was used to identify similar and identical 
residues among the resulting TpsA proteins. WebLogo 3 was used for presentation 
of the ClustalW alignment (Crooks et al., 2004). 
 
Adherence assay 
 
Adherence to rat lung epithelial cells (L2) was performed as described (Cotter et al., 
1998). 
 
Semi-native polyacrylamide gel analysis of FHA MCD 
 
Overnight cultures (25 mL) of BPSMAQ and BPSMAQT-N were grown to OD600 of 3-
5. Cultures were spun down at 11,000 r.p.m. for 10 min at 4°C. Supernatants were 
collected and sterilized using a 0.22 µm PVDF Millex-GV syringe-driven filter unit 
(Millipore). Two milliliters of ProBond slurry were added to filter-sterilized 
supernatants and the mixes were incubated end-over-end for 1 h at room 
temperature. The slurry-supernatant mixes were spun at 3,500 r.p.m. for 5 min and 
supernatant set aside. The pelleted resin was washed twice in Native Binding Buffer 
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and twice in Native Washing Buffer. The pelleted resin was then washed twice in 
250 mL of Native Elution Buffer (500 mM imidazole), with each wash and the resin 
being saved for analysis. Samples can be stored overnight at 4°C. Samples were 
resolved on 6% SDS-PAGE gel (10 mL loaded). The gel was stained by Coomassie 
blue to assess elution yields. The elution with the highest FHA yield was dialyzed in 
1 L sterile PBS pH 7.4 overnight at 4°C to remove excess imidazole. TEV buffer 
(20X), 1 mL (10 units) AcTEV protease and 1 mM DTT (final) were added to 
dialyzed samples. Samples were incubated at 30°C for 6 h. Two hundred and fifty 
microliters of ProBond resin was added to the samples and samples were incubated 
end-over-end overnight at 4°C to remove N-terminal portion of TEV protease-
cleaved FHA from the supernatant, leaving behind cleaved MCD in the flow-through. 
Fifteen microliters of the flow-through sample was added to 15 mL of 2X Native 
Sample Buffer. Samples were incubated at room temperature or 95°C for 5 min. 
Samples were resolved on 0.6% and 2.0% SDS-PAGE gels. 
 
Proteinase-K digest of purified MCD 
 
For digest of native MCD, 100 ng of protein was digested with various 
concentrations of proteinase-K (from 0 to 100 µg/mL) for 15 min at RT. Sample 
buffer (2X) was then added to each digest. After boiling, samples were separated 
using SDS- PAGE, transferred to nitrocellulose, and probed with the anti-MCD 
antibody. For digest of denatured/renatured MCD, 1 mg of protein was incubated in 
50 mL 6 M guanidinium-HCl for 30 min at 50°C, then raised to 1 mL with PBS and 
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concentrated using 10 kDa MW cut-off centrifugation filters. The sample was then 
resuspended in PBS and incubated for 30 min at 37°C, vortexing consistently. 
Samples were then split, loading 1/10 of each sample into individual tubes and 
digested with various concentrations of proteinase-K (from 0 to 100 µg/mL) for 15 
min at RT. Sample buffer (2X) was then added to each digest. After boiling, samples 
were separated using SDS-PAGE, transferred to nitrocellulose, and probed with the 
anti- MCD antibody. Densitometry analyses were performed using ImageJ 
(Schneider et al., 2012). 
 
Accessibility of cysteine substitutions in the MCD 
 
Overnight cultures of RBX11, ΔPD, their respective cysteine substitutions and 
RBX20 were grown overnight. Cultures were spun down at 14,000 r.p.m. for 3 min. 
Supernatants were collected and sterilized with a 0.22 µm filter. Filter-sterilized 
supernatants were then concentrated using a Microcon Ultracel YM-100, spun at 
14,000 for 15 min until all supernatant had been concentrated. Columns were 
washed in 500 mL sterile PBS, pH 7.4. One hundred microliters of PBS was added 
to the columns; the columns were then inverted in the Eppendorf tube and spun to 
elute concentrated and washed supernatant protein. Samples were brought to 10 
mM DTT and incubated at room temperature for 30 min. Two microliters of 10 mM 
DyLight 680 Maleimide (1 mg in 100 mL DMF) was added to each sample to bring 
them to 0.2 mM DyLight. Samples were incubated for 2 h at room temperature. 
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Sample buffer (2X) was added to samples, which were resolved by SDS-PAGE gel, 
transferred to nitrocellulose membrane and analyzed by Western blot. 
 
Immunoblotting 
 
Whole-cell lysates and concentrated supernatants were prepared from Bordetella 
cultures as described (Mazar and Cotter, 2006). Samples were resolved by 5.0% 
and 8.0% polyacrylamide gels (2.0% SDS) as indicated in results section. For anti-
MCD immunodetection, IRDye 800CW Goat anti-Rabbit IgG (H + L) was used (Li-
cor, diluted 1:25,000). For anti-CRD immunodetection, IRDye 800CW Goat anti-
Chicken IgG (H + L) was used (Li-cor, diluted 1:15,000). For anti-PD 
immunodetection, IRDye 800CW Goat anti-Chicken IgG (H + L) and IRDye 700LT 
Goat anti-Chicken IgG (H+L) (Li-Cor, diluted 1:25,000) were used. For anti-HA 
immunodetection, IRDye 680LT Goat anti-Mouse IgG (H + L) was used (Li-Cor, 
diluted 1:15,000). For anti-BvgS immunodetection, IRDye 800CW Goat anti-Mouse 
IgG (H + L) was used (Li-Cor, diluted 1:25,000). Membranes were imaged on a Li-
Cor Odyssey infrared imaging system. 
 
Proteinase-K digestion of FhaB 
 
Bordetella bronchiseptica cultures were grown to an OD600 of 1.5-3.0. Three 
samples per strain of 2 OD units were spun at 5,000 r.p.m. for 10 min at 4°C to pellet 
bacteria. Supernatants were aspirated and pellets were suspended to 200 mL cold 
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HEPES buffer, pH 7.4. Samples were spun at 5,000 r.p.m. for 5 min at 4°C and 
supernatants were aspirated. Two hundred microliters of mock reaction buffer 
(HEPES, pH7.4), 1.0 µg/mL proteinase-K (Sigma-Aldrich) in HEPES, or 1.0 µg/mL 
proteinase-K with 1 mM PMSF (MP Biomedicals) in HEPES were added to each of 
the three samples per strain. Reactions proceeded for 30 min at 16°C. Two 
microliters of PMSF (1 mM final) were added to proteinase-K digested samples to 
neutralize digestion. All samples were spun at maximum speed for 1 min at room 
temperature and supernatants were aspirated. Whole-cell lysates were prepared, 
resolved and immunoblotted as described. 
 
Dot blot analysis 
 
Bordetella bronchiseptica cultures were grown to an OD600 of 2.0-4.0. Volumes 
equivalent to 2 OD units were spun at max speed for 1 min to pellet bacteria. 
Supernatants were aspirated and pellets were washed in PBS. Samples were spun 
again at max speed for 1 min and the wash was aspirated. Samples were 
suspended in 1 mL of PBS and split into 500 mL aliquots. Bacteria in one tube were 
boiled for 5 min to lyse cells. Intact and lysed cells in were spotted (50 mL) onto a 
nitrocellulose membrane using a Whatman® Minifold® I 96-well slot-blot array 
system. The membrane was blocked in 5% milk-PBS for 1 h. Immunodetection by 
anti-MCD and anti-HA primary antibodies and goat anti-rabbit and goat anti-mouse 
secondary antibodies proceeded as described (here and (Mazar and Cotter, 2006).  
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Growth of prodomain trans-conjugates 
 
In order to avoid cytotoxicty, bacterial cultures were grown overnight in Stainer-
Scholte media with a final MgSO4 concentration of 20 mM. After growth, cells were 
pelleted to remove media, washed three times, then suspended in fresh Stainer-
Scholte with no MgSO4 in order to induce expression of the plasmid-borne 
prodomain. 
 
Mouse experiments 
 
Isofluorane-anesthetized 6-8 week old female BALB/c mice were inoculated 
intranasally with 5x104 colony forming units of B. bronchiseptica in 50 µL volume 
phosphate-buffered saline. At specified times post-inoculation, all three lobes of right 
lungs were removed from mice for bacterial burden determination and the large lobe 
of the left lungs were removed for histopathology analysis. Protocol IACUC ID: 10-
134.0-B. 
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Appendix B – Strain and plasmid list 
 
Strain list 
 
Strain name Description Reference 
RBX11 RB50 containing a deletion of codons 
4-3203 of fhaS 
(Julio and 
Cotter, 2005) 
RBX11,ΔsphB1 RB50 containing a deletion of codons 
4-3203 of fhaS and a deletion of 
codons 5-1035 of sphB1 
This work 
RBX20 RB50 containing a deletion of codons 
4-3705 of fhaB and a deletion of 
codons 4-3203 of fhaS 
(Julio and 
Cotter, 2005) 
CTHA RBX11 containing nine codons 
encoding the HA epitope 
(YPYDVPDYA) following codon 3703 
in fhaB 
This work 
HAPRR RBX11 containing nine codons 
encoding the HA epitope 
(YPYDVPDYA) following codon 3375 
in fhaB 
This work 
HAPRR,ΔsphB1 RBX11 containing nine codons 
encoding the HA epitope 
(YPYDVPDYA) following codon 3375 
in fhaB and a deletion of codons 5-
1035 of sphB1 
This work 
BPSMAQ Bp strain containing His7 following 
Q72 and AcTEV following Y1871 in 
FhaB 
This work 
BPSMAQT-N Bp strain with His7 at Q72, AcTEV at 
Y1871, truncated at aa 2330, 
complemented to aa 2410 
This work 
ΔMCD-PD RBX11 with a stop codon after bp 
5943 
 
JS26 ΔMCD-PD::pJB51 substituting 
A1983C, containing codons 1815-
3710 followed immediately by a stop 
codon 
This work 
JS55 ΔMCD-PD::pJB127 substituting 
A1983C, containing codons 1815-
2588 followed immediately by a stop 
codon 
This work 
JS27 ΔMCD-PD::pJB52 substituting 
V2032C, containing codons 1815-
3710 followed immediately by a stop 
codon 
This work 
	   116	  
JS56 ΔMCD-PD::pJB128 substituting 
V2032C, containing codons 1815-
2588 followed immediately by a stop 
codon 
This work 
JS28 ΔMCD-PD::pJB53 substituting 
V2081C, containing codons 1815-
3710 followed immediately by a stop 
codon 
This work 
JS57 ΔMCD-PD::pJB129 substituting 
V2081C, containing codons 1815-
2588 followed immediately by a stop 
codon 
This work 
JS48 ΔMCD-PD::pJB87 substituting 
G2132C, containing codons 1815-
3710 followed immediately by a stop 
codon 
This work 
JS58 ΔMCD-PD::pJB130 substituting 
G2132C, containing codons 1815-
2588 followed immediately by a stop 
codon 
This work 
JS52 ΔMCD-PD::pJB93 substituting 
A2182C, containing codons 1815-
3710 followed immediately by a stop 
codon 
This work 
JS59 ΔMCD-PD::pJB131 substituting 
A2182C, containing codons 1815-
2588 followed immediately by a stop 
codon 
This work 
JS49 ΔMCD-PD::pJB88 substituting 
A2233C, containing codons 1815-
3710 followed immediately by a stop 
codon  
This work 
JS60 ΔMCD-PD::pJB132 substituting 
A2233C, containing codons 1815-
2588 followed immediately by a stop 
codon 
This work 
JS51 ΔMCD-PD::pJB89 substituting 
L2284C, containing codons 1815-
3710 followed immediately by a stop 
codon 
This work 
JS61 ΔMCD-PD::pJB133 substituting 
L2284C, containing codons 1815-
2588 followed immediately by a stop 
codon 
This work 
JS50 ΔMCD-PD::pJB90 substituting 
I2333C, containing codons 1815-
This work 
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3710 followed immediately by a stop 
codon 
JS62 ΔMCD-PD::pJB134 substituting 
I2333C, containing codons 1815-
2588 followed immediately by a stop 
codon 
This work 
JS53 ΔMCD-PD::pJB94 substituting 
A2382C, containing codons 1815-
3710 followed immediately by a stop 
codon 
This work 
JS63 ΔMCD-PD::pJB135 substituting 
A2382C, containing codons 1815-
2588 followed immediately by a stop 
codon 
This work 
JS54 ΔMCD-PD::pJB95 substituting 
A2432C, containing codons 1815-
3710 followed immediately by a stop 
codon 
This work 
JS64 ΔMCD-PD::pJB136 substituting 
A2432C, containing codons 1815-
2588 followed immediately by a stop 
codon 
This work 
HA-ΔCS HAPRR containing a deletion of 
codons 2217-2647 
This work 
HA-ΔCS,ΔsphB1 HAPRR,ΔsphB1containing a deletion 
of codons 2217-2647 
This work 
HA-ΔMCT HAPRR containing deletion of 
codons 2217-2471 
This work 
HA-ΔMCT,ΔsphB1 HAPRR,ΔsphB1 containing deletion 
of codons 2217-2471 
This work 
HA-ΔPNT HAPRR containing deletion of 
codons 2472-2647 
This work 
HA-ΔPNT,ΔsphB1 HAPRR,ΔsphB1 containing deletion 
of codons 2472-2647 
This work 
Δ28-PD RBX11 containing a stop codon in 
fhaB at position 2441 
(Mazar and 
Cotter, 2006) 
HA-ΔMCD HAPRR containing deletion of 
codons 1981-2471 
This work 
HA-ΔMCD,ΔsphB1 HAPRR,ΔsphB1 containing deletion 
of codons 1981-2471 
This work 
HA-ΔMNT HAPRR containing deletion of 
codons 1981-2216 
This work 
HA-ΔMNT,ΔsphB1 HAPRR,ΔsphB1 containing deletion 
of codons 1981-2216 
This work 
ΔMCT-PD RBX11::pEG7-TX containing codons 
2217-2441 followed immediately by a 
This work 
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stop codon 
ΔMCT-PD,ΔsphB1 RBX11,ΔsphB1::pEG7-TX containing 
codons 2217-2441 followed 
immediately by a stop codon 
This work 
ΔECT RBX11::pEG7-TX containing codons 
3417-3612 followed immediately by a 
stop codon 
This work 
ΔECT,ΔsphB1 RBX11,ΔsphB1::pEG7-TX containing 
codons 3417-3612 followed 
immediately by a stop codon 
This work 
ΔPRR-ECT Δ28-PD::pEG7-T-E containing 
codons 2228-3371 followed 
immediately by a stop codon 
(Mazar and 
Cotter, 2006) 
ΔPRR-ECT,ΔsphB1 RBX11,ΔsphB1::pEG7-T-E 
containing codons 2228-3371 
followed immediately by a stop 
codon 
This work 
ΔPD Δ28-PD::pEG7-T-N containing 
codons 2228-2588 followed 
immediately by a stop codon 
(Mazar and 
Cotter, 2007) 
ΔPD,ΔsphB1 RBX11,ΔsphB1::pEG7-T-N 
containing codons 2228-2588 
followed immediately by a stop 
codon 
This work 
HA-ΔECT HAPRR::pEG7-TX containing codons 
3417-3612 followed immediately by a 
stop codon 
This work 
HA-ΔMCTΔECT HA-ΔMCT::pEG7-TX containing 
codons 3417-3612 followed 
immediately by a stop codon 
This work 
HA-ΔMCTΔECT, 
ΔsphB1 
HA-ΔMCT,ΔsphB1::pEG7-TX 
containing codons 3417-3612 
followed immediately by a stop 
codon 
This work 
ΔPRR HAPRR containing deletion of 
codons 3364-3608 
This work 
ΔPK HAPRR containing a deletion of 
codons 3582-3601 
This work 
ΔPK,ΔsphB1 HAPRR,ΔsphB1 containing deletion 
of codons 3582-3601 
This work 
PDComp Δ28-PD::pEG7-T-C containing 
codons 2228-3710 followed 
immediately by a stop codon 
(equivalent to wild-type fhaB) 
(Mazar and 
Cotter, 2006) 
RBX11::pSJ22 ΔfhaS containing a plasmid insertion 
(null mutation) in fhaC 
(Julio and 
Cotter, 2005) 
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RBX11/pSP-PD-PRR RBX11 containing the medium copy 
plasmid pSP-PD-PRR 
This work 
RBX20/pSP-PD-PRR RBX20 containing the medium copy 
plasmid pSP-PD-PRR 
This work 
RBX11::pSJ22/pSP-
PD-PRR 
RBX11::pSJ22 containing the 
medium copy plasmid pSP-PD-PRR 
This work 
RBX11/pPD-PRR RBX11 containing the medium copy 
plasmid pPD-PRR 
This work 
PDComp/pPD-PRR PDComp containing the medium copy 
plasmid pPD-PRR 
This work 
ΔPD/pPD-PRR RBX11 containing the medium copy 
plasmid pPD-PRR 
This work 
ΔMCD-PD /pPD-PRR ΔMCD-PD containing the medium 
copy plasmid pPD-PRR 
This work 
RBX20/pPD-PRR RBX20 containing the medium copy 
plasmid pPD-PRR 
This work 
RBX11::pSJ22/pPD-
PRR 
RBX11::pSJ22 containing the 
medium copy plasmid pPD-PRR 
This work 
RBX11/pPD RBX11 containing the medium copy 
plasmid pPD 
This work 
PDComp/pPD PDComp containing the medium copy 
plasmid pPD 
This work 
ΔPD/pPD RBX11 containing the medium copy 
plasmid pPD 
This work 
ΔMCD-PD /pPD ΔMCD-PD containing the medium 
copy plasmid pPD 
This work 
RBX20/pPD RBX20 containing the medium copy 
plasmid pPD 
This work 
RBX11::pSJ22/pPD RBX11::pSJ22 containing the 
medium copy plasmid pPD 
This work 
RBX11/ pSP-PD RBX11 containing the medium copy 
plasmid pSP-PD 
This work 
PDComp/pSP-PD PDComp containing the medium copy 
plasmid pSP-PD 
This work 
ΔPD/pSP-PD RBX11 containing the medium copy 
plasmid pSP-PD 
This work 
ΔMCD-PD /pSP-PD ΔMCD-PD containing the medium 
copy plasmid pSP-PD 
This work 
RBX20/pSP-PD RBX20 containing the medium copy 
plasmid pSP-PD 
This work 
RBX11::pSJ22/pSP-PD RBX11::pSJ22 containing the 
medium copy plasmid pSP-PD 
This work 
DH5α E. coli molecular cloning strain BRL; 
Gaithersburg, 
MD 
	   120	  
SM10λpir Conjugation strain (Miller and 
Mekalanos, 
1988) 
RHO3 Conjugation strain (López et al., 
2009) 
 
Plasmid list 
 
Plasmid name Description Reference 
pEG7 Suicide plasmid used to 
construct B. pertussis and B. 
bronchiseptica strains 
containing co-integrates 
(Akerley et al., 1995) 
pEG7S sacB-containing allelic 
exchange plasmid used to 
construct B. bronchiseptica 
strains 
(Martínez de Tejada et al., 
1996) 
pSORTP1 Allelic Exchange vector for B. 
pertussis 
(Mazar and Cotter, 2006) 
pBBR1-MCS Bordetella self-replicating 
plasmid 
(Kovach et al., 1994) 
pSS4245 pBR322-based allelic 
exchange plasmid for use in 
Bordetella species. Contains 
I-SceI cleavage site and 
encodes restriction 
endonuclease, I-SceI, under 
the control of the pertussis 
toxin (ptx) promoter 
(Inatsuka et al., 2010) 
pEG7S-ΔsphB1 pEG7S derivative used to 
introduce the ΔsphB1 deletion 
mutation into B. 
bronchiseptica strains 
(Mazar and Cotter, 2006) 
pEG7-CTHA pEG7 derivative containing 
nucleotides corresponding to 
codons 3429-3710 followed 
immediately by a stop codon 
and then 500 bp 
corresponding to the region 
immediately 3′ of fhaB with 
nucleotides encoding the HA 
epitope following codon 3703 
This work 
pSS4245-HAPRR pSS4245 derivative containing 
nucleotides corresponding to 
codons 3208-3567 with 
nucleotides encoding the HA 
This work 
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epitope following codon 3375 
pSORTP1-Bp 
MCI/Y1871/AcTEV 
Bp mating vector for 
Y1871AcTEV mutagenesis in 
FhaB 
This work 
pSORTP1-SS 
Template/Q72His7 
Bp mating vector for Q72His7 
mutagenesis in FhaB 
This work 
pJB48 pEG7 derivative containing 
nucleotides corresponding to 
codons 1814-3710 of fhaB 
followed immediately by a 
stop codon  
This work 
pJB101 pEG7 derivative containing 
nucleotides corresponding to 
codons 1814-2588 of fhaB 
followed immediately by a 
stop codon  
This work 
pJB28 pCR2.1 derivative containing 
nucleotides 5441-7410 of 
fhaB. Used for QuickChange 
substitutions. QuickChange 
derivatives were subcloned 
into pJB48 and pJB101. 
This work 
pJB51 pJB48 in which codon 1983 
has been changed to encode 
Cys instead of Ala 
This work 
pJB127 pJB101 in which codon 1983 
has been changed to encode 
Cys instead of Ala 
This work 
pJB52 pJB48 in which codon 2032 
has been changed to encode 
Cys instead of Val 
This work 
pJB128 pJB101 in which codon 2032 
has been changed to encode 
Cys instead of Val 
This work 
pJB53 pJB48 in which codon 2081 
has been changed to encode 
Cys instead of Val 
This work 
pJB129 pJB101 in which codon 2081 
has been changed to encode 
Cys instead of Val 
This work 
pJB87 pJB48 in which codon 2132 
has been changed to encode 
Cys instead of Gly 
This work 
pJB130 pJB101 in which codon 2132 
has been changed to encode 
Cys instead of Gly 
This work 
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pJB93 pJB48 in which codon 2182 
has been changed to encode 
Cys instead of Ala 
This work 
pJB131 pJB101 in which codon 2182 
has been changed to encode 
Cys instead of Ala 
This work 
pJB88 pJB48 in which codon 2233 
has been changed to encode 
Cys instead of Ala 
This work 
pJB132 pJB101 in which codon 2233 
has been changed to encode 
Cys instead of Ala 
This work 
pJB89 pJB48 in which codon 2284 
has been changed to encode 
Cys instead of Leu 
This work 
pJB133 pJB101 in which codon 2284 
has been changed to encode 
Cys instead of Leu 
This work 
pJB90 pJB48 in which codon 2333 
has been changed to encode 
Cys instead of Ile 
This work 
pJB134 pJB101 in which codon 2333 
has been changed to encode 
Cys instead of Ile 
This work 
pJB94 pJB48 in which codon 2382 
has been changed to encode 
Cys instead of Ala 
This work 
pJB135 pJB101 in which codon 2382 
has been changed to encode 
Cys instead of Ala 
This work 
pJB95 pJB48 in which codon 2432 
has been changed to encode 
Cys instead of Ala 
This work 
pJB136 pJB101 in which codon 2432 
has been changed to encode 
Cys instead of Ala 
This work 
pSS4245-ΔCS pSS4245 derivative containing 
nucleotides corresponding to 
codons 2048-2216 and 2648-
2808 of fhaB 
This work 
pSS4245-ΔMCT pSS4245 derivative containing 
nucleotides corresponding to 
codons 2048-2216 and 2472-
3640 of fhaB 
This work 
pSS4245-ΔPNT pSS4245 derivative containing 
nucleotides corresponding to 
This work 
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codons 2295-2471 and 2648-
2808 of fhaB 
pSS4245-ΔMCD pSS4245 derivative containing 
nucleotides corresponding to 
codons 1800-1980 and 2472-
3640 of fhaB 
This work 
pSS4245-ΔMNT pSS4245 derivative containing 
nucleotides corresponding to 
codons 1800-1980 and 2217-
2400 of fhaB 
This work 
pEG7-ΔMCT-PD pEG7 derivative containing 
nucleotides corresponding to 
codons 2256-2441 of fhaB 
followed immediately by a 
stop codon 
This work 
pEG7-TX pEG7 derivative containing 
nucleotides corresponding to 
codons 3418-3612 of fhaB 
followed immediately by a 
stop codon 
This work 
pEG7-T-E pEG7 derivative containing 
nucleotides corresponding to 
codons 2228-3371 of fhaB 
followed immediately by a 
stop codon 
(Mazar and Cotter, 2006) 
pSS4245-ΔPRR pSS4245 derivative containing 
nucleotides corresponding to 
codons 3178-3363 and 500 
nucleotides beginning at 
codon 3609 of fhaB 
This work 
pSS4245-ΔPK pSS4245 derivative containing 
nucleotides corresponding to 
codons 3400-3581 and 500 
nucleotides beginning at 
codon 3602 of fhaB 
This work 
pSJ22 pEG7 derivative containing an 
internal fragment of fhaC for 
disruption 
(Julio and Cotter, 2005) 
pSP-PD-PRR pBBR1-MCS derivative 
containing nucleotides 
encoding the fhaB promoter, 
signal peptide, prodomain, 
and PRR/ECT 
This work 
pPD-PRR pBBR1-MCS derivative 
containing nucleotides 
encoding the fhaB promoter, 
This work 
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prodomain, and PRR/ECT 
pPD pBBR1-MCS derivative 
containing nucleotides 
encoding the fhaB promoter 
and prodomain 
This work 
pSP-PD pBBR1-MCS derivative 
containing nucleotides 
encoding the fhaB promoter, 
signal peptide and prodomain 
This work 
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Appendix C – Strain and plasmid construction 
 
Strain construction 
 
RBX11Δ,sphB1 was constructed by performing allelic exchange on RBX11 using 
plasmid pEG7S-ΔsphB1 as described (Martínez de Tejada et al., 1996). The strain 
was confirmed to be constructed as intended by PCR and nucleotide sequence 
analysis. 
 
HAPRR and HAPRR,ΔsphB1 were constructed by performing allelic exchange on 
RBX11 and RBX11,ΔsphB1, respectively, using plasmid pSS4245-HAPRR as 
described (Inatsuka et al., 2010). The strains were confirmed to be constructed as 
intended by PCR and nucleotide sequence analysis. 
 
HA-ΔCS and HA-ΔCSΔ,sphB1 were constructed by performing allelic exchange on 
HAPRR and HAPRR,ΔsphB1, respectively, using plasmid pSS4245-ΔCS. The 
strains were confirmed to be constructed as intended by PCR and nucleotide 
sequence analysis. 
 
HA-ΔMCT and HA-ΔMCT,ΔsphB1 were constructed by performing allelic exchange 
on HAPRR and HAPRR,ΔsphB1, respectively, using plasmid pSS4245-ΔMCT. The 
strains were confirmed to be constructed as intended by PCR and nucleotide 
sequence analysis. 
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HA-ΔPNT and HA-ΔPNT,ΔsphB1 were constructed by performing allelic exchange 
on HAPRR and HAPRR,ΔsphB1, respectively, using plasmid pSS4245-ΔPNT. The 
strains were confirmed to be constructed as intended by PCR and nucleotide 
sequence analysis. 
 
HA-ΔMCD and HA-ΔMCD,ΔsphB1 were constructed by performing allelic exchange 
on HAPRR and HAPRR,ΔsphB1, respectively, using plasmid pSS4245-ΔMCD. The 
strains were confirmed to be constructed as intended by PCR and nucleotide 
sequence analysis. 
 
HA-ΔMNT and HA-ΔMNT,ΔsphB1 were constructed by performing allelic exchange 
on HAPRR and HAPRR,ΔsphB1, respectively, using plasmid pSS4245-ΔMNT. The 
strains were confirmed to be constructed as intended by PCR and nucleotide 
sequence analysis. 
 
ΔPRR was constructed by performing allelic exchange on HAPRR using plasmid 
pSS4245-ΔPRR. The strain was confirmed to be constructed as intended by PCR 
and nucleotide sequence analysis. 
 
ΔPK and ΔPK,ΔsphB1 were constructed by performing allelic exchange on HAPRR 
and HAPRR,ΔsphB1, respectively, using plasmid pSS4245-ΔPK. The strains were 
confirmed to be constructed as intended by PCR and nucleotide sequence analysis. 
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BPSMAQ was constructed by performing allelic exchange on BPSM using plasmids 
pSORTP1-Bp MCI/Y1871/AcTEV and pSORTP1-SS Template/Q72His7. The strains 
were confirmed to be constructed as intended by PCR and nucleotide sequence 
analysis 
 
BPSMAQT-N was constructed by introducing pEG7-FI1a/C&R-N into BPSMAQ by 
conjugation and selecting co-integrates on BG-Sm-Gm agar as described (Akerley 
et al., 1995) Integration of plasmids at the correct site in the chromosome was 
confirmed by PCR. 
 
CTHA was constructed by introducing pEG7-CTHA into RBX11 by conjugation and 
selecting co-integrates on BG-Sm-Gm agar. Integration of the plasmids at the 
correct site in the chromosome was confirmed by PCR. 
 
ΔMCT-PD and ΔMCT-PD,ΔsphB1 were constructed by introducing pEG7-ΔMCT-PD 
into RBX11 and RBX11,ΔsphB1, respectively, by conjugation and selecting co-
integrates on BG-Sm-Gm agar. Integration of the plasmids at the correct site in the 
chromosome was confirmed by PCR. 
 
ΔECT, ΔECT,ΔsphB1, HA-ΔECT, HA-ΔMCTΔECT, and HA-ΔMCTΔECT,ΔsphB1 
were constructed by introducing pEG7-TX into RBX11, RBX11,ΔsphB1, HAPRR, 
HA-ΔMCT, and HA-ΔMCT,ΔsphB1, respectively, by conjugation and selecting co-
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integrates on BG-Sm-Gm agar. Integration of the plasmids at the correct site in the 
chromosome was confirmed by PCR. 
 
 
ΔPRR-ECT,ΔsphB1 and ΔPD,ΔsphB1 were constructed by introducing pEG7-T-E 
and pEG7-T-N, respectively, into RBX11,ΔsphB1 by conjugation and selecting co-
integrates on BG-Sm-Gm agar. Integration of the plasmids at the correct site in the 
chromosome was confirmed by PCR. 
 
JS26, JS55, JS27, JS56, JS28, JS57, JS48, JS58, JS52, JS59, JS49, JS60, JS51, 
JS61, JS50, JS62, JS53, JS63, JS54, and JS64 were constructed by introducing -
pJB51, pJB127, pJB52, pJB128, pJB53, pJB129, pJB87, pJB130, pJB93, pJB131, 
pJB88, pJB132, pJB89, pJB133, pJB90, pJB134, pJB94, pJB135, pJB95, and 
pJB136, respectively, into ΔMCD-PD by conjugation and selecting co-integrates on 
BG-Sm-Gm agar. Integration of the plasmids at the correct site in the chromosome 
was confirmed by PCR. 
 
RBX11/pSP-PD-PRR, RBX20/pSP-PD-PRR and RBX11::pSJ22/pSP-PD-PRR were 
constructed by introducing pSP-PD-PRR into RBX11, RBX20 and RBX11::pSJ22, 
respectively, by conjugation and selecting trans-conjugates on BG-Sm-Cm agar. 
Plasmid acquisition was confirmed by PCR. 
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RBX11/pPD-PRR, PDComp/pPD-PRR, ΔPD /pPD-PRR, ΔMCD-PD/pPD-PRR, 
RBX20/pPD-PRR, and RBX11::pSJ22/pPD-PRR were constructed by introducing 
pPD-PRR into RBX11, PDComp, ΔPD, ΔMCD-PD, RBX20, and RBX11::pSJ22, 
respectively, by conjugation and selecting trans-conjugates on BG-Sm-Cm agar. 
Plasmid acquisition was confirmed by PCR. 
 
RBX11/pPD, PDComp/pPD, ΔPD /pPD, ΔMCD-PD/pPD, RBX20/pPD, and 
RBX11::pSJ22/pPD were constructed by introducing pPD into RBX11, PDComp, ΔPD, 
ΔMCD-PD, RBX20, and RBX11::pSJ22, respectively, by conjugation and selecting 
trans-conjugates on BG-Sm-Cm agar. Plasmid acquisition was confirmed by PCR. 
 
RBX11/pSP-PD, PDComp /pSP-PD, ΔPD /pSP-PD, ΔMCD-PD/pSP-PD, RBX20/pSP-
PD, and RBX11::pSJ22/pSP-PD were constructed by introducing pSP-PD into 
RBX11, PDComp, ΔPD, ΔMCD-PD, RBX20, and RBX11::pSJ22, respectively, by 
conjugation and selecting trans-conjugates on BG-Sm-Cm agar. Plasmid acquisition 
was confirmed by PCR. 
 
Plasmid construction 
 
pJB28 is a pCR2.1 derivative that contains a PCR-amplified 2.0 kb fragment of 
RBX11 fhaB (corresponding to codons 1814 through 2470). 
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The following plasmids are pEG7 derivatives used to construct co-integrate strains. 
Sequences cloned into this plasmid between the gentamicin resistance gene and 
ampicilin resistance gene are described. 
 
pJB48 contains PCR-amplified 2.0 kb, and 3.8 kb fragments of RBX11 fhaB 
(corresponding to codons 1814 through 2470 and codons 2471-3710 followed by a 
STOP codon) from RBX11 ligated together. 
 
pJB101 contains PCR-amplified 2.0 kb, and 350 bp fragments of RBX11 fhaB 
(corresponding to codons 1814 through 2470 and codons 2471-2588 followed by a 
STOP codon) from RBX11 ligated together.  
 
pJB51, pJB52, pJB53, pJB87, pJB93, pJB88, pJB89, pJB90, pJB94 and pJB95 
contain PCR-amplified 2.0 kb, and 3.8 kb fragments of RBX11 fhaB (corresponding 
to codons 1814 through 2470 and codons 2471-3710 followed by a STOP codon) 
from RBX11 ligated together with a QuickChange mutagenesis of the residues 
specified in plasmid list. 
 
pJB127, pJB128, pJB129, pJB130, pJB131, pJB132, pJB133, pJB134, pJB135 and 
pJB136 contain PCR-amplified 2.0 kb, and 350 bp fragments of RBX11 fhaB 
(corresponding to codons 1814 through 2470 and codons 2471-2588 followed by a 
stop codon) from RBX11 ligated together with a QuickChange mutagenesis of the 
residues specified in plasmid list. 
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pEG7-CTHA contains PCR-amplified 0.6 kb (corresponding to codons 3429 through 
3703) and 0.5 kb fragments of RBX11 fhaB (corresponding to codon 3703 extending 
to 457 bp 3′ of STOP codon) ligated together with nucleotides encoding an HA 
epitope following codon 3703. 
 
pEG7-TX contains PCR-amplified 0.6 kb (corresponding to codons 3418 through 
3612) followed immediately by a STOP codon. 
 
The following plasmids are pSS4245 derivatives used for allelic exchange in B. 
bronchiseptica. Sequences cloned into this plasmid between the I-SceI cleavage site 
and the tetracycline resistance gene are described. 
 
pSS4245-HAPRR contains PCR-amplified 0.5 kb (corresponding to codons 3208 
through 3375) and 0.6 kb fragments of RBX11 fhaB (corresponding to codons 3375 
through 3567) ligated together with nucleotides encoding an HA epitope following 
codon 3375.  
 
pSS4245-ΔCS contains PCR-amplified 0.5 kb (corresponding to codons 2048 
through 2216) and 0.5 kb fragments of RBX11 fhaB (corresponding to codons 2648 
through 2808) ligated together. 
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pSS4245-ΔMCT contains PCR-amplified 0.5 kb (corresponding to codons 2048 
through 2216) and 0.5 kb fragments of RBX11 fhaB (corresponding to codons 2472 
through 2640) ligated together. 
 
pSS4245-ΔPNT contains PCR-amplified 0.5 kb (corresponding to codons 2295 
through 2471) and 0.5 kb fragments of RBX11 fhaB (corresponding to codons 2648 
through 2808) ligated together. 
 
pSS4245-ΔMCD contains PCR-amplified 0.5 kb (corresponding to codons 1800 
through 1980) and 0.5 kb fragments of RBX11 fhaB (corresponding to codons 2472 
through 3640) ligated together. 
 
pSS4245-ΔMNT contains PCR-amplified 0.5 kb (corresponding to codons 1800 
through 1980) and 0.5 kb fragments of RBX11 fhaB (corresponding to codons 2217 
through 2400) ligated together. 
 
pSS4245-ΔPRR contains PCR-amplified 0.5 kb (corresponding to codons 3178 
through 3363) and 0.5 kb fragments of RBX11 fhaB (beginning at codon 3609 and 
extending past the fhaB stop codon) ligated together. 
 
pSS4245-ΔPK contains PCR-amplified 0.5 kb (corresponding to codons 3400 
through 3581) and 0.5 kb fragments of RBX11 fhaB (beginning at codon 3602 and 
extending past the fhaB stop codon) ligated together. 
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The following plasmids are pBBR1-MCS derivatives used for trans-conjugation in B. 
bronchiseptica. Sequences cloned into this plasmid into the lacZ gene are 
described. 
 
pSP-PD-PRR contains a 600 bp fragment (corresponding to the fhaB promoter and 
signal peptide) and a 3.6 kb fragment (corresponding to the fhaB prodomain) ligated 
together. 
 
pPD-PRR contains a 400 bp fragment (corresponding to the fhaB promoter) and a 
3.6 kb fragment (corresponding to the fhaB prodomain) ligated together. 
 
pPD contains a 400 bp fragment (corresponding to the fhaB promoter) and a 2.6 kb 
fragment (corresponding to the beginning of the fhaB prodomain) ligated together. 
 
pSP-PD contains a 600 bp fragment (corresponding to the fhaB promoter and signal 
peptide) and a 2.6 kb fragment (corresponding to the beginning of the fhaB 
prodomain) ligated together. 
 
The following plasmids are pSORTP1 derivatives used for allelic exchange in B. 
pertussis. Sequences cloned into this plasmid between the gentamicin resistance 
gene and ampicilin resistance gene are described. 
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pSORTP1-Bp MCI/Y1871/AcTEV contains PCR-amplified 600 bp fragments flanking 
the codon for Y1871 of RBX11 fhaB with nucleotides encoding an AcTEV cleavage 
site inserted following Y1871. 
 
pSORTP1-SS Template/Q72His7 contains PCR-amplified 600 bp fragments flanking 
the codon for Q72 of RBX11 fhaB with nucleotides encoding a His7 epitope inserted 
following Q72. 
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